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ABSTRACT 
The significance of any drugs, therapeutic proteins, or any bioactive compounds, 
is based not only on their effects on diseases but also on how specifically, how readily, 
how controllable and how prolonged their effects on the disease without having any side 
effects. Thus the techniques involved in the drug encapsulation and its controlled release 
for a longer duration of time form one of the important processes of drug reformulation. 
In recent years nanoparticles have created overwhelming attention for delivering drugs by 
nanoencapsulation. The smaller size of nanoparticles has longer circulation time and 
higher cellular uptake when compared with larger size of microparticles. Thus, the field 
of nanotechnology through its subsections of nanomedicine and biomedical 
nanotechnology is revolutionizing the pharmaceutical industries. The purpose of this 
research work is to nanoengineer bioresponsive materials for its application as a template 
for making submicron or nanosized drug delivery systems. 
The first half of this work deals with alginate template, a semi-synthetic polymer. 
Alginate has been reported as suitable for encapsulation of many bioactive agents like 
cells, enzymes, and drugs, owing to its relatively aqueous environment within the 
alginate matrix, the mild room condition encapsulation process, and high gel porosity. 
Recently biotechnological innovations have introduced some new forms of drugs with 
therapeutic proteins and oligonucleotides. Hence, submicron or nanoemulsions with 
narrow particle size ranges are becoming favored over larger particulate and/or 
iii 
iv 
polydisperse systems. This work deals in detail with the optimization of the size of 
calcium alginate nanoparticle preparation by the emulsification technique. By the 
optimized emulsion method calcium alginate nanoparticles of 300 nm in diameter can be 
prepared. These nanoparticles were later used for encapsulation and release of curcumin. 
Earlier, the smallest alginate particle produced had a minimum size of 1-5 urn; hence, 
this work remains as a frontrunner in the preparation of calcium alginate nanoparticles. 
The second half of this work deals with a natural nanotubular template called 
halloysite. Halloysite is tubular alumina silicate clay of 15-200 nm inner lumen diameter 
and 0.5-5 microns long. It was used for loading poorly soluble drugs and sustaining their 
release. Loading was optimized by varying pH and alcohol / water ratio in the solvent 
with a maximum drug loading of 12 % by volume. Near linear release of dexamethasone, 
furosemide, and nifedipine was demonstrated for 5-10 hours. The presence of silicates on 
halloysite outer surface provides a negatively charged exterior, and makes it possible to 
do Layer-by-Layer (LbL) assembly of positively charged polyelectrolytes and 
nanoparticles on halloysite. The LbL assembly was later extended to dexamethasone 
drug-loaded halloysite for its controlled release. A study of the effect of number of 
assembled layers and the effect of molecular weight of the assembled polymers on the 
release profile of the drug revealed that a high molecular weight of the assembled 
polymers and an optimum number of layers gave a very slow sustained release. 
Encapsulation of the drugs inside the lumen of the halloysite coupled with LbL assembly 
of clay-drug composite provides a novel formulation for controlled release of drugs. 
V 
Biocompatibility is a major problem for many materials to be used as a drug 
constituent. The cytotoxicity studies for halloysite were also done in this work to ensure 
the valid application of halloysite in drug reformulations. 
Halloysite clay was also demonstrated as a nanoreactor for synthesizing silver 
nanoparticles. Synthesis was carried out by reducing the silver acetate which was loaded 
inside the halloysite. This in situ synthesis offers a novel way of fabricating surface 
modified clay materials, nano-rod metals, core-shell type ceramic nanocomposites, and 
potential application in antimicrobial coatings and wound healing. 
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CHAPTER 1 
INTRODUCTION 
In the past few decades much research has been done in the field of 
Nanotechnology, a science to create nanodevices and nanostructures. This drive has been 
mainly inspired from our mother nature, as she stood as a perfect prototype for the 
Nanoindustry operating in 'bottom up' process for these many years. The fabrication of 
materials by building from the atomic scale is very attractive for delivering increased 
functionality, but practical difficulties lie in such precise construction. However, by using 
some of the nanomaterials (natural or synthetic) the fabrication process has become 
simpler but still remains challenging based on technological limitations. In the field of 
drug delivery, one of the most promising biomedical applications of nanotechnology, the 
use of nanomaterials as nanocarriers for improving the delivery methods, has shown 
advantageous technically and viable economically. These nanocarriers, formed by the 
process of nanoencapsulation are of two types, named as nanospheres and nanocapsules. 
Nanospheres have a matrix type structure in which the active ingredient may be absorbed 
on the sphere's surface or encapsulated within the particle [1]. On the other hand 
nanocapsules have the active ingredient confined within a liquid core enclosed by a 
membrane made by polymer [1, 2]. This work makes an effort to nanoengineer some 
bioresponsive materials as template for making submicron or nanosized drug delivery 
systems through the study of surface chemistry at micro and nanoscale. 
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Importance of Template Size 
A wide range of particle sizes (0.5 - 3400 urn) was used for drug delivery based 
upon the method employed and the nature of formulation [3]. However, currently due to 
biotechnological revolution and nanotechnological innovations the advent of proteins, 
oligonucleotides, DNA, polymers, micelles, micro emulsions, colloidal suspensions etc. 
as therapeutic agents have reduced that particle size lower limit to 1 nm. 
It appears that nanospheres would be most appropriate for proteins and nucleic 
acid based therapeutics where it is crucial that the therapeutic carrier must enter cells and 
escape endosomal and lysosomal attack and deliver their cargo by transport through 
cytosol [4]. Poly (DLlactide-co-glycolide) nanospheres that escaped endolysosomal 
attack within 10 minutes of uptake as a result of reversal of their surface charge in the 
acidic endo-lysosomal compartment is one such rationally designed drug delivery system 
[5]. Also, one should note that smaller sized nanoparticles showed twenty-seven-fold 
higher transfection than larger nanoparticles in cell lines when other parameters like 
surface charge, cellular uptake and release profile were the same between them [6]. 
Because most of the drug delivery systems are spherical, it has been shown that a 
maximum circulation time of 48 hrs has been achieved for spherical particles (100 - 200 
nm in diameter) in blood stream, and particles greater than 200 nm in diameter are 
cleared much faster than that [7-9]. Moreover, small particles with narrow size 
distributions have more predictable pharmacokinetics and pharmacodymanics. Hence, 
size does matter in determining templates for drug delivery systems. 
3 
Importance of Template Shape 
Many of common drug delivery systems based on liposomes or polymer 
micelles are spherical in shape. Hence the interaction of spherical particles with cells and 
within animals has been studied extensively, but the effect of shape has received very 
little attention. Water soluble carbon nanotubes are known to be cleared within hours 
from the body on intravenous injection. Recently, Discher et al. [10] filomicelles 
(filamentous polymeric micelles) between 22-60 nm across and 2-8 um long remain in 
the blood longer than their spherical counterparts. Hence, based upon the circulation time 
the shape of the template is also important in determination of proper template for drug 
delivery. 
Nature and Availability of Template 
These parameters determine the economical aspects of the drug delivery systems. 
If it is a natural material and available in huge quantities then the cost involved for 
making drug delivery systems will be much less. But some of disadvantages of naturally 
available material are variation in the properties and size range with respect to its 
source. 
If it is synthetic or artificial then it will be available in low quantities, and the cost 
involved for making drug delivery systems will be very high in comparison to naturally 
available templates. But the advantage is the control over the size range and the 
properties of the template. 
Hence, a tradeoff has to be made between source and availability in determining 
the usage of templates for designing drug delivery systems. 
4 
Research Goals 
In this research work, two bioactive materials were considered as a prospective 
template for designing drug delivery systems. The first is the semisynthetic, spherical 
alginate particle and the second one is a natural nanotubular clay template, known as 
halloysite. This work was developed on a step by step basis based upon following some 
of goals, which are as follows: 
• Preparing alginate spherical nanoparticles; 
• Utilizing spherical alginate nanoparticles for loading and release of drug; 
• Studying the application of halloysite in detail for nanoencapsulation and 
controlled release of drugs; 
Dissertation Overview 
This dissertation has been organized into several individual chapters, and some 
redundancy has been maintained to make those chapters a more comprehensible and 
contiguous piece of work. Chapter 2 gives a brief overview of the background needed for 
this dissertation. It covers the properties and earlier applications of alginic acid, used for 
making alginate particles and halloysite. Further, it gives a brief overview of introductory 
methods used to encapsulate and release macromolecules. Moreover, various 
characterization methods for the encapsulation and release of the macromolecules are 
explained. 
Chapter 3 describes the process of making alginate nanoparticles by 
emulsification technique and optimization of that process. These prepared alginate 
particles were used to study the loading and release of curcumin. Chapter 4 discusses the 
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use of halloysite for encapsulation and controlled release of poorly soluble drugs, namely 
dexamethasone, furosemide and nifedipine by simple mechanical means. 
Chapter 5 describes the application of Layer-by-Layer assembly for tunable 
controlled release of dexamethasone. It is shown that an optimum three bilayers of very 
high molecular weight natural polymers gave best controlled release. Chapter 6 proves 
the biocompatibility of halloysite by in vitro cytotoxicity studies with 3T3 and MCF7 
cells. 
Chapter 7 extends the application of halloysite as a nanoreactor for template 
synthesis of silver/silver oxide nanoparticles. Chapter 8 concludes the dissertation by 
giving an overview of the encapsulation and release techniques used. Future works that 
can be added to these encapsulation experiments are also given. 
CHAPTER 2 
BACKGROUND AND THEORY 
In this chapter the literature concerning two bioactive materials of our interest 
spherical alginate particles and nanotubular halloysite clay was reviewed. Also the 
literature concerning LbL technique used to nanoengineer these biomaterials is reviewed. 
Relevant instrumentation and theory used are presented for more clarity to understand the 
references of the same in the following sections. 
Spherical Alginate Particle 
Biocompatible biodegradable materials have received much attention as drug 
delivery vehicles for controlled release preparation [11, 12] and scaffolds for tissue 
engineering [13, 14]. Among them, alginic acid has been extensively investigated [13-
39]. 
Chemical Composition and 
Structure 
Alginates are a family of unbranched polysaccharides consisting of 1 - 4 linked, 
a-D mannuronic acid (M) and R-L-guluronic acid (G) residues (Figure 2.1). They are a 
principal component of the cell walls of several brown algae. Depending upon their 
source, they can have different chemical (e.g., complexation) or physicochemical (e.g., 
biopolymer rigidity) natures due primarily to the relative proportions and sequences of 
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the M and G residues. Gelation occurs by cross-linking of the sodium alginate with 
calcium ions [13-16]. Gluronic-rich alginates are characterized by a higher affinity for 
divalent metals because of a "zig-zag" structure that can easily accommodate divalent 
cations, i.e., the "egg-box model" [16]. Other dimetal and trimetal cations can be used to 
cross linked alginate [17-19], as well as different polycation such as chitosan [20-25] or 
poly-L-lysine [26]. In some cases other techniques, for example thermal gelation of 
secondary component (Pluronic), can be used [27]. 
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Figure 2.1: Alginic acid structure. M- mannuronic acid block, G - guluronic acid block 
[15]. 
Procedure for Preparing 
Calcium Alginate Particles 
Three main experimental techniques are useful for preparation of calcium alginate 
beds and particles. The most developed technique is emulsification with external addition 
of soluble gelation agent, which is CaC12 in most cases, also sometimes referred to as 
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emulsification/external gelation [16, 26, 28-37]. The emulsification/internal gelation 
involves insoluble, usually calcium, salts with slow pH lowering to release the cation and 
form calcium alginate matrix [37-39]. One more method, complex coacervation, usually 
involves precipitation of alginic acid from aqueous solution by polycationic chitosan [20-
25]. Mixed approaches are also used [26]. The general procedure for preparing calcium 
alginate micro particles is as follows. 
Typically, 37.5g isooctane were stirred for 1 min at 2000 rpm, 1.06 g SPAN 85 
were added and stirred for another 1 min. Then 25 g 3 % degassed alginate solution were 
added and stirred for 4 min. The mixture was moved to ultrasonication system, the batch 
was iced and ultrasonicated at 48% power for 2 min, and then it was moved back to the 
stirring system and 0.56 g TWEEN 85 in 2.50 g isooctane were added. The stirring was 
continued for 5 min at 2000 rpm. Than lOg of 10% CaC12 (pH 9) preliminary filtered 
through 0.20 um syringe filter were added and stirred for 5 min at 2000 rpm and then at 
1000 rpm for 15-20 min. To separate microparticles, 500 ml DI water was placed into a 
separation funnel, and the mixture was poured in and intensively but briefly shaken. Then 
after 30 min, when organic and aqueous layer were well distinguishable, microparticles 
were collected from the middle surfactant layer and centrifuged at 5000 rpm for 10 min. 
The supernatant was removed; the microparticles were washed with ethanol three times 
and finally dispersed in DI water. 
The microparticles obtained by following the general procedure have an average 
diameter of 1454.4 nm and polydispersity of 0.041. The surface charge of the 
microparticles is negative with the average value of-28.29 ± 2.35 mV. 
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CLSM and SEM images of prepared calcium alginate microparticles are presented 
in Figure 2.2 and Figure 2.3 respectively. The diameter of nanoparticles varies from 2.5 
to 0.5 micrometers. For confocal microscopy imaging, polyallylamine hydrochloride 
(PAH) labeled with a fluorescent dye RBITC was added to the suspension of calcium 
alginate microparticles. Positively charged polyelectrolyte PAH- RBITC forms a 
complex with negatively charged surface of calcium alginate microparticles and helps to 
visualize the particles. 
A B 
Figure 2.2: CLSM (A-fluorescence mode, B-transmission mode) images of calcium 
alginate microparticles prepared via emulsion technique. For fluorescence image, PAH-
RBITC was coated at pH 6.5. 
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Figure 2.3: SEM images of calcium alginate microparticles prepared via emulsification 
technique. Images were taken after sputter coating the dried sample with 2 nm thickness 
of Iridium. 
Applications 
Polysaccharides such as alginates have been used extensively in the food, 
cosmetics, pharmaceutical and biomedical industries for their gel-forming properties in 
the presence of multivalent cations. Microencapsulation in calcium alginate 
microparticles has been widely used for the immobilization of lactic acid bacteria owing 
to its ease of handling, nontoxic nature, and low cost (27-29). Alginate encapsulation has 
been reported as suitable for many biological and biologically active components 
including cells [40], enzymes [33-35], and drugs [29-32, 36]. 
Several macromolecular drug delivery systems are based on calcium alginate (Ho 
and Neufeld, 2001 [41]; Guet al , 2004 [42]). Besides release through diffusion out of the 
calcium alginate gel, swelling and erosion of the drug delivery system has been described 
as the major source of release of encapsulated macromolecular drugs (Murata et al., 1993 
[43]). Correlation between the calcium alginate swelling-erosion rate and drug release 
rate allowed Kikuchi's team to produce a pulsatile drug delivery system characterized by 
a controlled lag time before release (Kikuchi et al., 1997 [44]). Chretien's team has 
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shown that alginate impregnated in the acryl microspheres controlled the release rate of 
low molecular weight drugs [45]. 
Although an exhaustive amount of work has been done on alginate microparticle 
preparation and its use in drug delivery, only a limited amount of research has been done 
for alginate particles less than 1 micron. Those nanosizes are found to be extremely 
important for making protein or nucleic acid based therapeutic delivery systems. Earlier, 
the smallest alginate particle produced had a minimum size of 1-5 um [46,47]. 
Nanotubular Clay Particles- Halloysite 
Halloysite is a two-layered aluminosilicate which has a predominantly hollow 
tubular structure in the submicron range and is chemically similar to kaolinite [48, 49]. 
These minerals are formed from kaolinite over millions of years due to the action of 
weathering and hydrothermal processes [50]. Layers are rolled into nanotubes due to the 
strain caused by lattice mismatch between adjacent silicone dioxide and aluminum oxide 
sheets [48, 50, 51]. 
Halloysite is mined from natural deposits in countries such as USA, Australia, 
New Zealand, Korea, China, and Turkey. The largest deposit in the United States is at the 
Dragon Mine in Utah [49, 51, 52, 53, 54]. 
Chemical Composition and 
Structure 
Halloysite occurs in nature as hydrated mineral that has the ideal chemical 
formula of Al2Si20s(OH)4.2H20, which is similar to kaolinite except for the presence of 
an additional water monolayer between the adjacent layers. It is also called halloysite -
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(10A) due to its layer thickness close to 10 A. Heating halloysite - (10A) can easily and 
irreversibly dehydrate to form halloysite - (7A) [48, 50, 51, 55, 56]. 
Besides aluminum and silicone oxides and water of hydration, halloysite minerals 
were observed to contain trace amounts of other metal oxides such as iron, chromium, 
titanium, etc [50, 51]. Therefore it is difficult to assess the exact chemical composition of 
the halloysite minerals [51]. 
Iron oxide is the most common impurity observed in halloysite minerals (up to 
12.8 wt %). This high amount of iron oxide may be due to the presence of associated iron 
oxides in mineral as well as due to the isomorphous substitution of Fe for Al in the 
octahedral alumina sheet [51]. According to Joussein et al. Fe has never been reported 
to substitute Si+4 in the tetrahedral sheet of halloysite [51]. A typical chemical analysis of 
the halloysite from New Zealand is shown in Table 2.1. 
Table 2.1: Chemical analysis of New Zealand halloysite (Source: Imery's Tableware 
New Zealand Ltd, Halloysite MP # 47/04). 
Chemical Analysis 
Ignition Loss 
Si02 
A1203 
Fe203 
Ti02 
CaO 
MgO 
K20 
Na20 
Total 
% 
14.9 
45.4 
38.2 
0.48 
0.12 
<0.02 
<0.09 
<0.01 
<0.05 
99.62 
In Figure 2.4 and Figure 2.5 the schematic structure of halloysite - (7A) 
nanotubes and kaolinite layer are shown respectively. Halloysite layer, which has a 
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characteristic 7.2 A of thickness, is structurally similar to the kaolinite layer [51, 57]. The 
outside diameters of the tubes vary from 40 to 190 nm, with an average value of 70 nm. 
The diameters of internal lumen range from 15 to 100 nm and average 40 nm [48]. The 
lengths of tubules cover wide a range of 1 to 20 um [49]. 
Halloysite forms by kaolinite layer rolling due to the action of weathering and 
hydrothermal processes [50]. In halloysite nanotubes silica layer is relevant to the outer 
surface of tube, while the alumina layer is relevant to the inner surface [50, 51]. One of 
the possible reasons for the formation of halloysite tubules is the lattice mismatch 
between adjacent tetrahedral silica sheets and octahedral alumina sheets that causes the 
formation of strain in platy layer [48, 50, 51]. In kaolinite minerals that strain is reduced 
by rotation of alternate silica tetrahedrons blocked in hydrated halloysite minerals due to 
the presence of interlayer water molecules [51]. 
Bates et al. showed that halloysite - (7A) nanotubes were collapsed to form laths 
or ribbons which were due to the intralayer strain produced by dehydration of halloysite -
(10A) to halloysite - (7A) [1]. No evidence of hexagonal-shaped flakes was found 
although splitting and unrolling may lead to the formation of rectangular laths. The tube 
terminations of uniform character were also not observed [48]. 
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Figure 2.4: Schematic representation of halloysite-(7A) nanotubes [123]. 
inner OH groups 
outer OH groups 
Figure 2.5: Structure of kaolinite layer [57]. 
Morphology 
The particle morphology of halloysite nanotubes depends on their geological 
occurrences and crystallization conditions and varies from tubular to platy or tabular in 
shape. Chemical compositions of different morphologies are also different. Platy 
halloysite particles always contain relatively large amounts of iron than tubular particles 
[51]. Figure 2.6 shows the variations in the morphology of the halloysite from different 
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sources and within one source the size distribution varies a lot. Figure 2.7 shows the size 
distribution in a halloysite sample of New Zealand. 
S^Sb 
Figure 2.6: TEM images of dried halloysite from different source a. China, b. New 
Zealand, and c. USA (Utah). 
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Figure 2.7: Particle size distribution of halloysite from New Zealand (Source: Imery's 
Tableware New Zealand Ltd, Halloysite MP # 47/04). 
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Physical and Chemical 
Properties 
Halloysite minerals have relatively high specific surface areas (SSA) which vary 
from 50 to 140 m g" with deposit. They are abundant with narrow cylindrical pores. 
Therefore they can absorb relatively big class of compounds from inorganic salts (such as 
the salts of alkaline metals and ammonia) [51, 58] to organic molecules (such as ethanol, 
glycerol, acetone, dimethylsulphoxide, formaldehyde) [51, 59, 60] as well as polymers 
and biologically active agents (such as tetracycline hydrochloride, khellin, nicotinamide 
adenine dinucleotide, and Poly-ethylene Glycol) [49, 55]. 
Absorption of salts and small organic molecules mainly take place mainly by their 
intercalation into interlayer space [51, 55, 58], whereas big polymer molecules, proteins 
and drugs, are bound to its outer and inner faces [49, 55]. Intercalation does not occur 
with polymers, proteins, and other macromolecules due to their large molecular size [55]. 
Among all of the organic compounds, only the ones that have small molecular sizes and 
hydrophilic functional groups such as -OH and -NH2 were observed to form an 
intercalation complex with halloysite nanotubes, possibly due to the formation of 
hydrogen bonds between them and alumina or silica layers [51, 55, 59, 60]. 
The adsorptive and ion exchange properties of halloysite nanotubes are highly 
affected by their surface charges which are pH-dependent [50, 51]. Surface charge pH 
dependence of kaolinite and halloysite were studied by Tari et al. in [50]. Zeta potential 
curves of both halloysite and kaolinite fall between the curves of Si02 and a-A1203 
indicating that both materials contribute to the surface charges of observed minerals. 
However, halloysite has higher negative surface charge compared with kaolinite showing 
the predominance of silica properties at the outer surface [50]. 
17 
Capillary Force 
The capillary force which helps in higher adsorption of several materials is 
calculated by using the following simple formula, with notes on the dimension in SI 
units, the height h of a liquid column (m) is given by [61]: 
h = (2y cos0) / (pgr) 
where: 
y is the liquid-air surface tension (J/m2 or N/m) 
9 is the contact angle 
p is the density of liquid (kg/m3) 
g is acceleration due to gravity (m/s2) 
r is radius of tube (m) 
For a water-filled tube in air at sea level, 
y is 0.0728 J/m2 at 20 °C 
9 is 20° (0.35 rad) 
pis 1000 kg/m3 
g is 9.8 m/s2 
therefore, the height of the water column is given by: 
h = (1.4xl0"5)/r 
For halloysite nanotubes of average inner radius of 7nm the capillary force 
interms of height of the water column is h ~ 2000 m (in terms of atmosphere h ~ 200 
atm). Hence it is understandable that this much higher capillary force helps halloysite in 
quick adsorption of several materials. 
18 
Applications 
Before the discovery of their fine nanotubular structuring, halloysite minerals 
have widely been used in the production of the porcelain products, and bone china. 
Establishment of their structure and other exciting physicochemical properties opened a 
broad range of new applications for these abundantly available materials [51]. 
Halloysite nanotubes can replace carbon nanotubes or boron nitride nanotubes in 
a number of nanotechnology applications in which chemistry of the tubes is less 
important [62]. These nanotubes can be loaded with the big variety of other metal ions 
(such as Fe+2, Fe+3, Ni+2, Cu+2, Bi+3, Ag+1) by mixing them with concentrated solution of 
corresponding metal nitrate or chloride and subjecting the obtained mixture into a 
vacuum jar. The procedure of vacuum pulling can be repeated several times to increase 
the amount of loaded substance. Loading efficiency of halloysite nanotubes vary from 
trace amounts to almost 100% depending on the loaded substance. Potential exists to 
modify loaded compounds inside halloyside nanotube by heating or electron irradiation 
to produce insulated nanorods and nanowires with specific magnetic and electric 
properties [62]. 
Besides inorganic salts, halloysite nanotubes can also be filled with a large range 
of organic and biologically active agents including lubricants, herbicides, pest repellents, 
pharmaceuticals, cosmetics, food and personal products, as well as other agents that 
could benefit from a controlled release [49, 51, 55, 56, 63]. Having chemically different 
external (silicone dioxide) and internal (aluminium oxide) surface structure, halloysite 
nanotubes offer scope for chemical control of preferential internal, rather than external 
loading of desired compounds [62]. Price et al studied the release profiles of 
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oxytetracycline hydrochloride (water soluble antibiotic), khellin (vasodilator that 
promotes hair growth) and nicotinamide adenine dinucleotide - NAD (an important 
coenzyme in many biochemical reactions including fatty acid and nucleic acid 
biosynthesis) from halloysite nanotubes [49]. Agents were loaded to halloysite from 
water solution or molten state by using vacuum jar. To reduce the release rate for 
oxytetracycline hydrochloride, it was loaded to halloysite nanotubes together with 
compatible polymeric material epoxy Quitol 651. Before loading hydrophobic agent -
khellin, water associated with halloysite was removed by heating the clay in ethylene 
glycol at 100 °C [49]. 
Due to their porous structure and chemically active external and internal surfaces 
halloysite particles can be used in the remediation of acid mine drainage, water 
purification in refining industries, as well as in the separation of liquids and gaseous 
mixtures [51]. Kutsuna et al. studied catalytic degradation of tetrachloroethene (CC12 = 
CC12) on halloysite and kaolinite under photoillumination. This substance is widely used 
for cleaning metals and semiconductors and causes groundwater pollution [64]. 
Schukin et al. studied the possibility of using the inner lumen of halloysite tubes 
as nanoreactors for biomimetic synthesis of inorganic substances. Authors used the 
reaction of urease catalysed deposition of CaC03 into halloyside nanotubes as a model 
reaction to demonstrate the possibility of conducting enzymatic biomineralization inside 
the pores of halloysite particles [65]. 
Complete loading of halloysite nanotubes was achieved by immersion of urease 
loaded halloysite particles in a half-molar (0.5M) water solution of urea and calcium 
chloride for 30 min (Figure 2.8) [65]. 
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Figure 2.8: SEM images of halloysite nanotubes before A) and after B) loading with 
CaC03 [65]. 
Halloysite nanotubes, having negative surface charge, can be used in production 
of thin films with specific enzymatic properties by using layer-by-layer (LbL) 
nanoassembly technique. Lvov et al. analyzed the structure of thin films produced by 
sequential adsorption of Polyethyleneimine (PEI) and halloysite nanotubes (Figure 2.9) 
[66]. 
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Figure 2.9: SEM image thin film, produced by LbL deposition of halloysite, 
Polyethyleneimine and Polystyrenesulfonate. A) Cross - section view, B) top view [66]. 
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The assembly of Alcohol dehydrogenase (ADH) - an enzyme that catalyses the 
oxidation of alcohols to aldehydes in the presence of the cofactor Nicotineamide Adenine 
Dinucleotide (NAD), and halloysite multilayers - was also achieved. This work promises 
the production of enzymatic microreactor by the assembly of NAD-loaded halloysite 
nanotubes and ADH. Slow release of NAD from halloysite nanotubes, deposited together 
with ADH enzyme into polymer film by LbL technique, can extend the period of 
enzymes catalytic activity [66]. 
Lu et al. studied the effect of coating of lignocellulose wood fibers (used for the 
production of paper) with halloysite and other particles by using LbL nanoassembly. 
Although coating of wood fibers with halloysite slightly reduced paper brightness and 
tensile strength, it drastically increased the porosity. High-porous papers produced by 
LbL nanoparticle coating can be used in pharmaceutical and biomedical applications such 
as nano drug reservoirs for molecular loading and controlled release [52]. 
Modification of electrical, physicochemical properties of halloysite particles was 
achieved by their surface coating with metals and other substances. Such coated particles 
are ideal for use in electronic fabrication and other high-tech ceramic composite 
applications [51, 53]. Baral et al. carried out the metallization of halloysite particles by 
using electroless plating technique to deposit a thin nickel film on the surface of 
halloysite nanotubes [53]. Before metallization, the surface of halloysite particles was 
activated by acidic palladium chloride (PdC12) solution and acidic stannous chloride 
(SnC12) solution. Activation of the surface can be explained by the formation of small 
palladium metal particles on the substrate surface. These particles catalyze metal ion 
reduction on halloysite external surface [53]. 
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Halloysite nanotubes were plated in Niposit468 nickel plating bath. This method 
was known to deposit up to 99.9% pure ferromagnetic nickel metal on substrate surface. 
The efficiency of halloysite particle coating was verified by EDX elemental analysis 
which showed that 95.5 atom% of metallic nickel is present within a 5-10 nm depth of 
substrate surface. TEM analysis of nickel-coated halloysite particles indicated that the 
average thickness of nickel film is about 20 nm [53]. 
Preliminary Work 
Some preliminary work was done with halloysite to understand the effect of 
morphology on loading and release of a poorly soluble drug, dexamethasone. Figure 2.10 
shows the effect of the halloysite source on the release profile of dexamethasone drug. 
The China halloysite has a very slow release because the morphology of these tubes 
(Figure 2.6 a) are very short and has a lower lumen diameter when compared with the 
rest, and the New Zealand halloysite has a very fast release, that can be attributed to the 
presence of longer nanotubes (Figure 2.6 b) and as well as large hollow cones peculiar to 
halloysite from New Zealand. 
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Figure 2.10: Dexamethasone release comparison in water from halloysite of different 
source: loading done from drug saturated water solvent. 
Loading of halloysite with DNA Oligomer was experimented by pulling vacuum 
in a single step, as the fluorescein tagged DNA Oligomer is highly sensitive to light. The 
loading is done at three different pH conditions and the amount of DNA loaded is found 
out by observing the difference in the fluorescence intensity of fresh DNA solution and 
spent DNA solution (after halloysite adsorption) using fluorescence spectrophotometer. 
To confirm the presence of DNA inside the lumen a TEM image of loaded halloysite was 
taken. 
It is very difficult to decipher the presence of DNA Oligomer inside the lumen 
from the TEM image of loaded halloysite (Figure 2.11). However the presence of Uranyl 
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acetate material inside the lumen, which negatively stains the DNA, confirms the 
presence of DNA inside the lumen. Further, the amount of loading increases with the 
decrease in pH (Figure 2.12). We know that halloysite has an inner alumina layer and 
outer silica layer and, from our characterization, the net negative charge decreases with 
decrease in pH, suggesting an increase in the positive charge of inside alumina layer. This 
positive charge aids in more adsorption of negatively charged DNA electrostatically. 
Hence, this experiment reaffirms that the DNA Oligomer adsorbed is present inside the 
lumen having alumina layer, acting as a driving force for the loading of DNA. 
A B 
Figure 2.11: TEM picture of Unloaded Halloysite (A) and DNA oligomer loaded 
halloysite (B). 
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Figure 2.12: DNA loading variation with respect to pH: loading using water as solvent. 
Nanotubular structure and variety of specific physicochemical properties make 
halloysite particles impressive in a broad range of nanotechnology applications including 
being nanocapsules for biologically active substances, production of thin polymer films 
by LbL nanoassembly, modification of paper properties, etc. However, the potentials for 
the applications of these naturally abundant materials have not been totally discovered. 
There is no doubt that further in-depth research on halloysite will open new technological 
and biomedical application areas for these exciting nanotubes. 
Layer-by-Layer Assembly 
Nanoencapsulation of drugs involves the formation of drug-loaded particles with 
diameters ranging from 1 to 100 nm [67]. It describe the preparation of nanoscale 
assemblies, which can be relatively simple nanoemulsions, nanoparticles, polymer 
conjugates of proteins or drugs, or complex multicomponent systems containing drugs, 
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proteins, or genes, as well as arrays of targeting ligands and/or signal systems, to enable 
in vitro or in vivo detection. Currently, only two nanoparticle products, Doxil® and 
Abraxane® have been approved by FDA for clinical use in cancer chemotherapy. But 
many more are being developed and are in phase I, II, or III of the drug development 
process. These complex nanosized products are formed either by self-assembling or 
involve covalent conjugation techniques. The bioactive materials used to fabricate such 
drug delivery packages typically include synthetic or semi-synthetic polymers such as 
poly-ethylene glycol, and/or natural materials such as lipids, dendrimers, biopolymers, 
and proteins. Formation of nanoshells is one method of making drug delivery systems. 
Among the nanoshells the metallic nanoparticles with a dielectric core having thin 
metallic coating [68-74] and nanoshells formed by electrostatic Layer-by-Layer (LbL) 
self-assembly [75] are the most widely studied nanoshells. In this work the materials 
under consideration for study (Alginate and Halloysite) are not dielectric, hence the 
background and theory of electrostatic LbL assembly was discussed in detail. 
In the last 10-15 years, electrostatic Layer-by-Layer self-assembly has been 
developed as a pragmatic, versatile, reliable and simple method to form nanoshells by 
several researchers like Lvov et al. [75-79], Tieke et al. [80]. The Layer-by-Layer (LbL) 
nanoencapsulation method involves the formation of a nanothick shell around a core of 
any shape and size. The desirable features of LbL assembly are that the nanoshell is 
stable, permeable, compatible, and allows the release of the core material through it. 
Depending upon the usage of core templates, the cores are divided into two types namely 
"passive" (such as 50 - 300 nm latex or silica), which later will be dissolved to provide 
space for active ingredient, and "active" (such as drug, protein, and DNA) which itself 
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acts as functional ingredient. The ease with which we can tailor several varieties of 
biofunctional materials as cores [82] and as well as shells [75, 76, 78, 79] was one of the 
key advantage of electrostatic Layer-by-Layer assembly. Of recently, only general 
aspects of this method have been studied, however still further elaboration and 
understanding is needed to achieve its complete potential. 
Preparation of LbL 
Nanoshells 
The sequential adsorption of oppositely charged colloids was reported in a 
seminal paper in 1966 by Her [81]. The technique of LbL self-assembly for thin films by 
means of alternate adsorption of oppositely charged linear polyions was then further 
developed in the early 1990s [82-85]. The basis of the method involves resaturation of 
polyion adsorption, resulting in the reversal of the terminal surface charges of the film 
after deposition of each layer. 
Layer-by-Layer self-assembly can construct an ultrathin film via alternate 
adsorption of oppositely charged polyions, nanoparticles, and biomolecules. The obtained 
films have thicknesses in the nanometer range and tunable properties to their 
environment, such as permeability, solubility, and morphology [77, 86-89]. The 
development of polyelectrolyte microcapsules is based on LbL assembly on nano or 
microscale cores, for instance cells, and inorganic or organic particles, including drugs, 
which have recently gained intensive attention [82, 90-95]. 
Cores with diameters ranging from nanometers to microns are coated with 
alternating layers of linear polycations, polyanions, and other materials. After dissolving 
the cores, hollow microcapsules were gained with ordered walls of desired composition, 
and thicknesses in the range of 5 - 100 nm. The capsules have tunable permeability for 
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molecules of different sizes on the basis of open-and-close mechanisms by adjusting the 
environmental stimuli [96-102]. These capsules offer broad perspectives in 
encapsulation, transport, and controllable delivery of drugs, minerals, and proteins. 
Changing the pH value of solutions induces the formation of tiny pores in the nanometer 
range, allowing macromolecules to pass through the capsule walls [98, 101]; adjusting 
solution ionic strength or adding organic solvent will also influence permeability [95, 
100, 102]. These permeability controls are achieved by changing the charge densities of 
linear polyelectrolytes, resulting in relaxing the capsule walls. However, the austere 
conditions of these methods limit their use in the biomedical field for controlled drug 
delivery applications because they are often inconsistent with physiological conditions 
occurring within the human body. 
The basic scheme of the LbL assembly was shown in Figure 2.13 for 2D 
substrates and in Figure 2.14 for 3D substrates. A standard approach for film preparation 
can be obtained elsewhere [82, 84, 103]. 
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Figure 2.13: Scheme of electrostatic layer-by-layer self-assembly on 2-D substrates with 
(top) polycations and polyanions, and (bottom) polycations and negatively charged 
nanoparticles. 
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Figure 2.14: Scheme of electrostatic layer-by-layer self-assembly on 3-D microtemplates, 
or cores, followed by core dissolution. 
These methods provide the possibility of designing ultrathin multilayer films with 
a precision better than one nanometer of defined molecular composition. To date, these 
methods have been used with more than 50 different charged macromolecules. The 
polyions predominately used in the assembly are as follows: 
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• Polycations: chitosan (CH), gelatin A (GA), poly(allylamine 
hydrochloride) (PAH), poly(dimethyldiallylammonium chloride) (PDDA), 
polyethylenimine (PEI), poly-L-lysine (PLL), and protamine sulfate C (PS). 
• Polyanions: sodium carboxylmethyl cellulose (CMC), chondroitin sulfate 
sodium salt (CS), deoxyribonucleic acid (DNA), dextran sulfate sodium salt (DS), gelatin 
B (GB), heparin sodium salt (HEP), poly(acrylic acid) (PAA), poly(sodium 4-
styrenesulfonate) (PSS), poly(vinyl sulfate) (PVS), sodium alginate (SA), and tannic acid 
(TA). 
These charged materials can be combined with enzymes, antibodies, viruses, and 
inorganic nanoparticles to produce multifunctional shells in both 2-D and 3-D 
nanoassembly processes. The architecture of these shells can be designed with nanometer 
precision to meet different requirements such as thickness, biocompatibility, controlled 
permeability, targeting, and optical or magnetic properties. 
Any charged polyelectrolytes, polymers, nanoparticles, biomolecules, lipids and 
viruses can be used for LbL assembly process on any charged template of any shape and 
size. The only determining factor for successful assembly is the reversal of the charge 
upon deposition of the layers. This is achieved by selecting proper assembly conditions 
like pH, temperature and concentration of the assembling components [104]. The use of 
any kind of materials as coating component is often advantageous as proper selection of 
the materials helps us in achieving the desired mechanical strength, elasticity, electrical 
and optical characteristics of the shell, and other properties make them unique building 
blocks for the creation of composite materials. In addition, the incorporation of bioactive 
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compounds like drugs, therapeutic proteins and nucleic acids in multilayer films may lead 
to applications in biosensors, pharmacy, and biotechnology [99, 105, 106]. 
Nanoshells Monitoring 
For the time-dependent monitoring of LbL assembly in situ, a quartz crystal 
microbalance (QCM) is most often used because of its proven suitability [82, 107, 108]. 
First of all, the kinetics of the adsorption process can be delineated by the QCM 
technique, indispensable for establishing proper assembly conditions (e.g., saturation 
adsorption time). Multilayer assembly is generally characterized by means of the quartz 
crystal microbalance technique in two ways: 1) after drying a sample in a nitrogen 
stream, the resonance frequency shift is measured and the calculation of the adsorbed 
mass is done by the Sauerbrey equation; or 2) by monitoring of the resonance frequency 
during the adsorption process onto one side of the resonator, which is in permanent 
contact with the polyion solutions. The Sauerbrey equation is given as 
Af = ~ ^ (2.D 
pv 
where Af is the change in frequency, Am is the change in mass per surface area, f 
is the frequency of the resonator (9 MHz), p is the density of the quartz (2,650 kg-m"), 
and v is the propagation of sound in quartz (3,340 rn-s"1). In solution, QCM frequency 
shifts of about 800 Hz are seen for every adsorption cycle, which is more than that 
detected for a dried film of PSS/PAH. This difference is ascribed to the strong hydration 
of the most recently adsorbed layer. The bound water is included in the film, and is 
removed after drying, meaning that most polyion films swell by 40 - 60 % before drying, 
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and that only 5 - 10 % of the water remains in polyion films after drying. Figure 2.15 
shows the thickness of (PSS/PAH)2(TA/PAH)3 films adsorbed on QCM resonators. 
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Figure 2.15: Frequency shift and film thickness of each assembled layer for 
(PSS/PAH)2(TA/PAH)3 adsorption on QCM electrodes. The first two precursor layers are 
PSS/PAH, and the next three layers are TA/PAH. The tannic acid and poly(allylamine 
hydrochloride) has an average thickness of 1.57 ± 0.11 nm and 1.69 ± 0.35 nm, 
respectively [109]. 
Another method to check and confirm the assembly process is by observing the 
reversal of surface charge after each polymer or polyion coating as shown in Figure 2.16. 
The zeta-potential or surface potential, of the suspended nanoshells is measured after 
each layer has been applied. In Figure 2.16 negatively charged CD 40 DNA microspheres 
are used as cores, poly-L-lysine (PLL) as polycation, and carboxy methyl cellulose 
(CMC) as polyanion. Since the adsorption is carried out at a relatively high concentration 
of polymers (PLL), a number of charged ionic groups remain exposed at the outer surface 
even after the charge compensation or nullification by the cores, and thus the surface 
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charge is effectively reversed and helps in preventing further polymer (PLL) adsorption. 
The CD 40 microspheres are then washed by centrifugation to remove excess free 
polymers. The surface is then immersed in a solution of anionic CMC. Again, a layer is 
adsorbed, but now the original surface charge (negative) is restored, and the surface is 
ready for further assembly of positively charged polymers. These two steps are repeated 
alternately until a layer of the desired thickness is obtained. More than two components 
can be used in one assembly step as long as proper reversal of charges are observed for 
each subsequent adsorption [75, 82,110]. 
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Figure 2.16: Surface charge alternation of polymers poly -L-lysine (PLL) and carboxy 
methyl cellulose (CMC) coated on CD 40 DNA microspheres (Obtained from EPIC-
Therapeutics, a subsidiary of BAXTER Inc.) at pH 6.5. 
Visual confirmation of the layers assembled can be obtained by CLSM images. 
For example, Figure 2.17 shows the CLSM images of poly-L-lysine (PLL) coated 
microspheres. PLL coating can be observed by red rings due to its tagging by 
Rhodamine-iso-thio-cyanate and the microspheres in green due to its innate fluorescence. 
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Figure 2.17: CLSM images of poly-L-lysine coated CD40 DNA microspheres (Obtained 
from EPIC-Therapeutics, a subsidiary of BAXTER Inc.). For visualization poly-L-lysine 
was tagged with Rhodamine-iso-thio-cyanate (RITC). 
The growth steps of 1.1 - 2.0 nm for a bi-layer of polyelectrolytes are typical for 
alternate linear polyion assembly, and a thickness of one layer often equals to half of this 
value [111]. These values correspond to a polyion cross-section, and show that in one 
cycle of excessive adsorption, approximately one-monolayer coverage of the substrate 
takes place. The nanoparticle/polyion bi-layer thickness is determined by the diameter of 
the particles. Model fitting of X-ray data gives a surface roughness of the polyion film on 
the order of 1 nm, while atomic force microscopy and scanning electron microscopy data 
reveal a surface roughness of 1 - 2 nm [112]. Polyion films are insoluble in water and in 
many organic solvents, and are stable to 250 - 280 °C [113]. 
The polycation/polyanion bi-layer thickness depends on the charge density of the 
polyions. It was shown that more than 10 % of polyion side groups have to be ionized for 
a stable reproducible multilayer assembly via alternate electrostatic adsorption [114]. 
High ionization of polyions results in a smaller step of film growth ( 1 - 2 nm), and lower 
ionization gives a larger growth step ( 3 - 6 nm). It can be reached either by adding salt to 
a polyion solution (as discussed above for strong polyelectrolytes, such as PDDA and 
PSS), or by varying the pH for weak polyelectrolytes [86]. 
CHAPTER 3 
OPTIMIZATION OF ALGINATE MICRO / 
NANO PARTICLE PREPARATION AND 
ITS USE AS SPHERICAL TEMPLATE 
FOR ENCAPSULATION AND 
RELEASE OF CURCUMIN 
Introduction 
Alginate encapsulation has been reported as suitable for many biological and 
biologically active components including cells [40], enzymes [33-35], and drugs [29-32, 
36], owing to the relatively inert aqueous environment within the matrix, the mild room-
temperature encapsulation process, and high gel porosity allowing high diffusion rates of 
macromolecules. 
Most of the preparation methods have been developed for beds and microparticles 
of gelled alginic acid with sizes much greater than several microns, sometimes several 
tens of microns [15-35, 37-39]. At the same time, only a limited amount of research has 
been done for particles less than 1 micron, and especially, for those with diameter less 
than 300 nm that, as believed, are more promising for drug delivery applications [24-26, 
36]. 
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This work describes the development of a simple reproducible experimental 
approach to prepare calcium alginate nanoparticles with diameter less than 300 ran via 
emulsification technique. Emulsification is a well developed method to obtain micro and 
nanodroplets of target substance in continuous organic phase. Emulsification/external 
gelation technique is widely used to prepare calcium alginate nanoparticles with a 
diameter larger than several hundred of nanometers or several microns. Different 
parameters of preparation procedure were varied to reduce calcium alginate particle size 
considerably and achieve nanoparticles with diameter less than 300 nm. The following 
parameters were alternated: oil (organic) phase composition, oil/water phase ratio, 
hydrophobic/hydrophilic surfactant ratio, different surfactants, varying concentration of 
alginic acid solution, ratio between gelation agent (CaC12) and alginic acid, another 
gelling agent, type (source) of alginic acid with varying G/M ratio. 
Materials and Methods 
Alginic Acid 
The following different types of alginic acid were used: 
Alginic acid sodium salt of medium viscosity (Sigma, viscosity of 2% solution at 
20 0C is 225 mPas). 
Alginic acid sodium salt of high viscosity (FMC Biopolymer, Protanal LF 200 S, 
G/M 65%-75% / 25%-35%, viscosity (1% solution at 20 0C) is 200-400 mPas). 
Alginic acid sodium salt of medium viscosity (FMC Biopolymer, Protanal LF 
10/60 S, G/M 65%-75% / 25%-35%, viscosity (1% solution at 20 0C) is 20-70 mPas). 
Alginic acid sodium salt of medium viscosity (FMC Biopolymer, Protanal LFR 
5/60 S, G/M 65%-75% / 25%-35%, viscosity (1% solution at 20 0C) is <10 mPas). 
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Surfactants 
The following different surfactants were used: 
SPAN85 (Sigma), SPAN 20 (Sigma), TWEEN 85 (Sigma), and AOT (Bis(2-
ethylhexyl) sulfosuccinate sodium salt or Docusate sodium salt, Sigma Aldrich). 
Organic Solvents 
The following different organic solvents were used: 
isooctane (Sigma), cyclohexane (Sigma Aldrich), hexadecane (Sigma), hexane 
(Fisher Scientific), ethanol (Sigma), and chloroform (Fisher Scientific C298-500, Lot 
011399). 
In addition polygalacturonic acid potassium salt (Sigma), chitosan low molecular 
weight (Aldrich), and calcium chloride (Fluka) were used. 
Equipment 
A Cole-Parmer ultrasonic processor CPX750 and a Stir-pak laboratory mixer, 
model 50002-02, equipped with a stirring head, model 50002-40, were used for emulsion 
preparation. 
Eppendorf 5804R centrifuge was used to separate nanoparticles from supernatant, 
a Branson 1510 Sonicator resuspended nanoparticles after centrifugation. 
General Procedure to 
Prepare Calcium Alginate 
Nanoparticles by 
Emulsification Technique 
Typically, 37.5g isooctane were stirred for 1 min at 2000 rpm, 1.70 g SPAN 85 
were added and stirred for another 1 min. Then 25 g 3 % degassed alginate solution were 
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added and stirred for 4 min. The mixture was moved to ultrasonication system, the batch 
was iced and ultrasonicated at 80% power for 20 min, then 0.90 g TWEEN 85 in 2.80 g 
isooctane were added, and the ultrasonication was continued for 10 min at 2000 rpm. 
Then lOg of 10% CaC12 (pH 9), preliminary filtered through 0.20 um syringe filter were 
added and sonicated for 5 min at 2000 rpm and then stirred at 1000 rpm for 15-20 min. 
To separate microparticles, 500 ml DI water was placed into a separation funnel, the 
mixture was poured in and intensively but briefly shaken. After 30 min, when organic 
and aqueous layer were well distinguishable, microparticles were collected from the 
middle surfactant layer and centrifuged at 5000 rpm for 10 min. The supernatant was 
removed, the microparticles were washed with ethanol two times and finally dispersed in 
DI water. The particles were stored at 4°C. 
Characterization of Calcium 
Alginate Nanoparticles 
The measurements of nanoparticle hydrodynamic diameter and surface charge 
measurements were carried out on a ZetaPlus Brookhaven microelectrophoretic 
instrument in either water or ethanol. For the measurements, 0.1 mL of nanoparticle 
suspension was redispersed in 2 mL of the solvent of choice. 
The morphology of the particles was observed by taking SEM images on Hitachi 
S-4800 Scanning Electron Microscope. The samples for SEM imaging were typically 
prepared by applying 2-5 uL of diluted nanoparticles suspension in water or ethanol on 
the surface of Si template followed by overnight drying. To enhance image quality, the 
samples surface was spattered with 2 nm layer of iridium. 
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Confocal laser scanning microscopy (Leica DMI RE2) was also used to visualize 
the morphology of calcium alginate microparticles. Typically 2-5 uL of microparticles 
suspension was placed on a glass slide and the images were taken. 
Encapsulation of Curcumin 
Curcumin-loaded chitosan-alginate microspheres were prepared by complex 
coacervation-emulsification technique. Briefly, 1 g of 1% chitosan solution in 1 % acetic 
acid containing curcumin solution in ethanol was added concomitantly with 1 g of 1 % 
alginate solution into 50 g of light mineral oil ( Hexadecane) containing 0.5 g of Tween 
85. The mixture was homogenized (@2000 rpm) for 5 min and additional 10ml of 
hexadecane added, then sonicated for 5 min (@30 watt power) and then lOgm of 10% 
Calcium chloride solution is added and further sonicated for 5min. The obtained 
microspheres were then freeze-dried and kept in a tight, light-resistant container at -20oC 
for further studies. 
Release Kinetics Study of 
Curcumin In Vitro 
Around lmg of curcumin-loaded microspheres is taken and dispersed in 2ml of 
lOmM PBS buffer solution at pH 7.4 and its time-based absorbance is measured in a 
Glass UV-Vis spectrophotometer (Agilent-8453). The peak is observed at 434 nm. The 
rate of release was calculated based upon ethanol extraction of curcumin from 
microspheres. For comparison pure curcumin release in similar fashion is studied in a 
PBS buffer. 
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Results and Discussion 
Calcium alginate nanoparticles obtained by the general procedure have an average 
diameter of 269.4 nm and polydispersity of 0.114. The surface charge of the 
microparticles is negative with the average value of-17.98 ± 0.66 mV. 
CLSM images of obtained calcium alginate nanoparticles are presented in Figure 
3.1. The diameter of nanoparticles is much less than 1.0 micrometer. For confocal 
microscopy imaging to visualize the nanoparticles, polyallylamine hydrochloride PAH -
labeled with a fluorescent dye RBITC, which forms a complex with the negatively 
charged surface of calcium alginate nanoparticles - was added. 
A B 
Figure 3.1: CLSM images of calcium alginate nanoparticles, prepared by general 
emulsification method. For fluorescence mode imaging (B, left) PAH-RBITC was coated 
at pH 6.5. 
SEM images of the same particles are shown in Figure 3.2. The size of bigger 
particles was around 300 nm, most of the nanoparticles have a diameter of 200 nm, and 
the small ones are around 100 nm. According to the light-scattering measurements 
performed on a Brookhaven Zeta-sizer, the hydrodynamic diameter of the particles from 
the same sample is 317±5.95 nm. The data collected using Zeta-sizer give overestimated 
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value of nanoparticle size. The real diameter is 2/3 of the value obtained by light 
scattering. This result might be due to the hydrodynamic behavior of the particles in the 
water solvent (swelling of the particles by absorption of solvent) while measuring the 
particle size by light scattering. 
Figure 3.2: SEM images of calcium alginate nanoparticles, prepared by general 
emulsification method. Images were taken after sputter coating the dried sample with 2 
nm thickness of Iridium. 
Optimization of the Calcium 
Alginate Nanoparticle 
Preparation Procedure 
To optimize the procedure of calcium alginate nanoparticle preparation and 
prepare nanoparticles with diameter smaller than 300 nm, several experiments has been 
carried out by varying different parameters, such as: 
- Oil (organic) phase composition. Hexadecane, hexane, cyclohexane and 
sometimes chloroform were added to the oil phase, which was isooctane in most cases. 
The solvent mixtures have different viscosity, surface tension at the oil/water phase 
border, evaporation temperature, which can affect size of alginate emulsion droplets and 
in some cases favor the formation of nanoparticles of small sizes; 
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- ratio between oil and water phase; 
- concentration of alginic acid solution; 
- ratio between CaC12 and alginic acid; 
- ratio of hydrophobic surfactant SPAN85 to hydrophilic surfactant TWEEN 85. It 
can influence the size of initial alginic acid emulsion micelles. 
- other surfactants, such surfactants as SPAN20 and AOT were tried. SPAN20 is 
hydrophilic surfactant with shorter hydrophobic tail than SPAN85, and its application can 
probably decrease nanoparticles size. AOT is a well known stabilizer for oil-in-water 
emulsions. 
- another gelling agent. Ca-AOT was tried as a gelling agent. It allows avoiding 
the step of mixing prepared alginic acid emulsion with new portion of aqueous solution 
(CaC12) and might affect nanoparticle particle size. 
Influence of Oil Phase 
Composition, Alginic Acid 
Concentration and Ratio of 
Alginic Acid and CaCMised 
on Nanoparticles Size 
Calcium alginate nanoparticles were prepared by following the emulsification 
procedure given above. The changes introduced in the procedure to optimize sample 
quality and obtain nanoparticles of smaller size and the results on measurements of 
nanoparticle hydrodynamic diameter are given in Table 3.1. In several cases, 
nanoparticles of diameter less than 300 nm were prepared (Indicated in inclined and bold 
style format). Separate emulsification of alginic acid and calcium chloride followed by 
mixing of the emulsions under continuous stirring or sonication (see Exp-4 in Table 3.1) 
gives relatively better results than other tried approaches. The procedure consists of 
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separate emulsification of 10 ml of 10% CaCb solution in water and 5 g 3% alginic acid 
sodium salt in 37.5g (54.2 mL) isooctane containing 1.7 g SPAN 85 each by sonication at 
90% power for 30 min. The absence of hydrophilic surfactant TWEEN85 also seems to 
tend decrease the nanoparticle size. 
Table 3.1: Conditions and results of optimization of calcium alginate nanoparticles 
preparation via emulsification technique. 
Conditions 
different from 
general procedure 
General procedure 
Exp-l 
Exp-2 
5 gof 3 % alginate 
solution 
E x p - 3 
5 g 3 % alginate 
solution 
No TWEEN 
E X D - 4 
5 g 3 % alginate 
solution and lOg 10% 
CaCl2 were emulsified 
in 54.2 ml isooctane 
each and mixed 
No TWEEN85 
E x p - 5 
2 g 3 % alginate 
solution, 1.7 g SPAN 
85 and 1.5g TWEEN 
85 
54 ml isooctane+ 50 
ml hexadecane 
40 min total sonication 
time, 1 ml of 10% 
CaCl2 added under 
sonication 
E x p - 6 
2 g 3 % alginate, 2.8 g 
SPAN85andl.7g 
TWEEN 85, isooctane/ 
l':ir:imeters clumped 
relati\eh the general 
procedure 
Different fractions were 
collected. 
1) oil-to-water ratio 
decreased 5 times, 
2) otherwise the same, 
Different fractions were 
collected. 
1) oil-to-water ratio 
increased 5 times 
2) Only hydrophobic 
surfactant SPAN85 
l)separate emulsification 
of alginic acid and CaCl2 
followed by mixing 
2)Only hydrophobic 
surfactant SPAN85 
3)increased ratio oil-to-
water 
l)increased amount of oil 
phase, 
2)increased ratio 
hydrophilic/hydrophobic 
surfactant 
3) less volatile solvent 
4)longer sonication time 
5) decreased amount of 
CaCl2 
l)increased amount of oil 
phase 
2)increased amounts of 
both surfactants 
lla\drod}iiamic 
diameter, nm 
376.2±14.1 
317.0±5.9 
341.7+12.2 
424.0± 11.05 
298.2111.5 
2 3 8.2 ±11.0 
283.4±6.4 
180.6±4.4 
164.8+4.5 
742.1-801.9 
±21.8-25.3 
342.0-381.0 
±4.4-13.0 
Hall 
width, 
Nm 
152.1+19 
.3 
105.2±15 
.5 
131.8+14 
.2 
146.5±11 
.9 
105.8±19 
.2 
115.8+6. 
6 
150.2±2. 
6 
68.8±4.6 
53.4±5.7 
404.8-
441.8 
±13.9-
23.5 
140.8-
168.8 
±11.6-
8.9 
I'olydis-
I'ersily 
0.19±0.05 
0.13±0.04 
0.17±0.04 
0.16±0.03 
0.13±0.05 
0.2510.04 
0.2110.03 
0.1510.02 
0.1210.02 
0.30-0.31 
±0.02-0.03 
0.17-0.20 
±0.02-0.03 
Conditions 
different from 
general procedure 
hexadecane (1:1) oil 
phase 
2gl0% CaCl2 under 
stirring 
Exp-7 
Isooctane/hexadecane 
(l:l),2.8gSPAN85 + 
1.7gTWEEN85, l g 
10%CaCl2andlg3 
% alginate solution per 
50 mL oil phase each 
E x p - 8 
5 g 3 % alginate per 
37.5g isooctane +1.7 g 
SPAN 85,10g 10% 
CaCl2 per 37.5g 
isooctane+1.7 g 
SPAN 85 
E x p - 9 
5 g 3 % alginate, 2.3 g 
SPAN 20, no 
TWEEN85, Otherwise 
as Exp3 
Exp - 1 0 
1 g 3 % alginate 
solution 
Otherwise the same as 
Exp3 
Exp - 1 3 
25 mL hexane +5 mL 
chlorophorm, 2.5 mL 
1% alginate, 0.9 g 
SPAN85, 0.45g 
TWEEN85 
Exp - 1 4 
30 mL cyclohexane, 
0.9gSPAN85, 1.0 g 
TWEEN85,2 mL 1% 
alginate+ cyclohexane 
to 40 mL total 
volumes, 20 mL of the 
emulsion above in 5 
mL 10%CaCl2, 
Mixing 30 min 
Parameters changed 
relatively the general 
procedure 
3) less volatile solvent 
5) decreased amount of 
CaCl2 
l)increased amount of oil-
to-water 
2)increased amounts of 
both surfactants 
3) less volatile solvent 
4) separate emulsification 
of both components,5) 
mixing under stirring 
l)smaller amount of 
alginate solution, 
2)increased amount of oil-
to-water 
3)separate emulsification 
followed by mixing under 
sonication. 
1) smaller chain 
hydrophobic surfactant 
2) no TWEEN85 
l)much smaller amount of 
alginic acid 
2) large ratio CaC12 to 
alginate 
l)chlorophorm in oil phase 
1) Low concentration of 
alginic acid 
2) high ratio oil/water, 
3) cyclohexane as oil phase 
Hydrodynamic 
diameter, nm 
364.7-381.9 
±8.7-24.9 
240M1L9 
686.7±41.5 
291.6 
612.4±28.3 
Not stable 
emulsion 
302.5 ±16.8 
231.4+5.0 
Half 
width, 
Nm 
143.1-
157.7 
±9.4-
16.6 
112.15±7 
.25 
172.9±23 
.4 
-
371.7±10 
-
169.3+9. 
1 
111 .7+4. 
4 
Polydis-
Pcrsitv 
0.16-0.17 
±0.02 
0.22±0.02 
0.07±0.02 
-
0.38±0.03 
-
0.31+0.01 
0.23+0.01 
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Influence of Surfactant and 
Gelling Agent Nature on 
Nanoparticle Size 
Ca-AOT Preparation Procedure. Ca-AOT (Docusate calcium salt) was 
prepared by mixing 3.7 g Na-AOT in 100 ml methanol and 1.0 g CaC12 in 100 ml water. 
Solvent was evaporated to 75 mL and white precipitate was collected, washed with DI 
water three times to remove NaCl and dried. 
From the results shown in Table 3.2 one can see that AOT does not stabilize 
alginic acid and calcium chloride emulsions to a sufficient degree. Ca-AOT as a gelling 
agent-surfactant increases nanoparticle size. Both these approaches are considered 
unsuccessful. 
Table 3.2: Influence of surfactant and gelling agent nature on suspension stability and 
nanoparticle diameter. 
Conditions dilii-rcnt from »ciiu':il procedure 
Exp -11 
25 mL hexane, 0.75ml 0.1 M Na-AOT, 1.0 mL 3% 
alginate, 1.39 mL of ~30mM Ca-AOT in 0.1 mL 
increments under sonication 
Exp - 1 2 
25 mL hexane +3 mL chloroform, 0.75ml 0.1 M Na-
AOT, 0.5 mL 3% alginate, 3 mL of ~30mM Ca-AOT 
in 0.1 mL increments under sonication 
Exp - 1 5 
30 mL cyclohexane, 0.9 mL SPAN85, 1.0 mL 
TWEEN85 
2 mL 1% alginate+ cyclohexane to 40 mL total 
volumes 
a) 20 mL of the emulsion above +10 mL Ca-AOT 30 
mM, mixing 60 min 
b) mixture a) 10 mL 10 % CaC12 mixing, 
ultrasonication for 5 min 
l)Na-AOT as surfactant 
l)Ca-AOT as gelling 
agent 
3) Na-AOT as 
surfactant 
In a) Ca-AOT as 
gelation agent 
In a) 600 
In b) 600 
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Modification of Nanoparticle 
Washing and Separation 
Procedure 
While working with nanoparticles of small size, a problem in separation was 
identified. Very small particle size and material softness of Ca-alginate nanoparticles 
centrifugation from aqueous supernatant does not seem to be a good separation 
procedure. If centrifugation speed is high, the particles form a pellet on the bottom, which 
is very difficult to separate. If the centrifugation speed is too slow, a very big loss of the 
nanoparticles during washing was observed. In addition, if nanoparticle diameter is small 
and no hydrophilic surfactant is used, the final emulsion containing calcium alginate 
nanoparticles is very stable. It is difficult to break it and separate the nanoparticles. 
To overcome the difficulties, the following modifications were introduced into 
nanoparticle separation procedure. Ethanol was used to break the emulsion containing 
SPAN85 and wash the nanoparticles. 
1) The mixture obtained after addition of alginic acid emulsion to CaCk-
containing solution or emulsion (see paragraph 3.1 for details) was transferred into a 
separation funnel to separate isooctane phase containing SPAN85. No extra water was 
added. 100 mL of ethanol was added to the mixture to break the emulsion and easy 
separation. After 1 hour needed for phase separation transparent isooctane layer was 
discharged. SPAN85 was removed from the ethanol/water layer containing nanoparticles 
by multiple extractions with isooctane. Concentration of SPAN 85 in the isooctane 
extracts was estimated by UV-vis spectroscopy (an Agilent 8045 spectrometer). 
Extinction coefficients of SPAN85 (A,=268 nm) in isooctane and ethanol found by 
calibration of A (a.u) vs. Cspan85 (mg/ml) are 0.185 and 0.178 L g" cm" . 
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Calcium alginate nanoparticles were separated from ethanol/water supernatant by 
centrifugation at 2000 rpm for 15 min. The nanoparticles were washed either with ethanol 
only or once with ethanol and then with DI water. Centrifugation speed was increased if 
necessary but not exceeds 5000rpm. Finally, the nanoparticles were resuspended in water 
or ethanol and frozen at -80 C, in case of water. 
However, while only ethanol was used to break the emulsion and wash 
nanoparticles, another problem was discovered, such as the absence of a clearly visible 
layer of nanoparticles. That is why the changes below were introduced. 
2) To separate microparticles, 500 ml DI water was placed into a separation 
funnel, the mixture was poured in and intensively but briefly shaken. 100ml ethanol and 
50 ml of isooctane were added and shaken. After 30 min the top isooctane layer was 
discarded. 50 ml of isooctane were added to the bottom ethanol mixture containing 
particles and the above procedure was repeated. Nanoparticles were collected from the 
middle surfactant layer and centrifuged at 5000 rpm for 10 min. The supernatant was 
removed; the nanoparticles were washed with ethanol two times and finally dispersed in 
DI water. 
SPAN 85 concentration in 
Isooctane Extracts and 
Ethanol Supernatants 
Calcium alginate nanoparticles were prepared by separate emulsification of CaC12 
and alginic acid in isooctane -SPAN85 oil phase followed by their mixing under constant 
stirring or sonication. Only ethanol (no water) was used to break the emulsion. SPAN85 
was removed from the reaction mixture by multiple extractions with isooctane. The 
SPAN85 concentration in the supernatant was estimated spectrophotometrically (Table 
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3.3). Multiple extraction of SPAN85 with isooctane followed by washing nanoparticles 
with ethanol several times can remove SPAN85 from the samples almost completely. 
Table 3.3: Concentration of SPAN85 in supernatants (isooctane extracts and ethanol 
supernatants). 
Experiment 
S-3 
S-4 
Phase 
isooctane supernatant 
isooctane 1st extraction 
isooctane 2nd extraction 
ethanol supernatant 
supernatant isooctane 
1st wash isooctane 
2 nd wash isooctane 
supernatant ethanol 
1 st wash ethanol 
1 st wash with water 
C(SPAN85), g/I 
20.9 
2.9 
1.5 
18.1 
19.7 
8.0 
4.2 
7.7 
1.4 
~ 0 
Influence of Modified 
Separation Parameters on 
Nanoparticle Diameter 
Calcium alginate nanoparticles were prepared by separate emulsification 
of CaC12 and alginic acid in isooctane -SPAN85 oil phase followed by their mixing 
under constant stirring or sonication. Only ethanol (no water) was used to break the 
emulsion. SPAN85 was removed from the reaction mixture by multiple extractions with 
isooctane. The hydrodynamic diameter (Table 3.4) of the nanoparticles was measured 
using a Brookhaven Zeta plus analyzer instrument. 
SEM images of for Ca-alginate nanoparticles prepared according to the general 
procedure presented in Figure 2.3. The size of bigger particles is around 300 nm, most of 
the nanoparticles have a diameter of 200 nm, and the small are around 100 nm. The SEM 
images of calcium alginate nanoparticles obtained using the modified separation and 
washing procedure are presented in Figure 3.3. The sample (S-2) consists of 
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nanoparticles with diameter less 300 nm, however, some 400 nm diameter nanoparticles 
are visible. It should be noted that the measured hydrodynamic diameter of nanoparticles 
in this sample is 439.7 nm. 
Table 3.4: Calcium alginate nanoparticle size for samples prepared according to modified 
separation procedure. 
Conditions 
different from 
general 
procedure 
S-l 
General procedure 
S-2 
5.6 mg of 3% 
alginic acid was 
used. . 
S-3. 
S-4 
double amount of 
SPAN 85 was used. 
Particles separation and washing 
steps 
General procedure 
No water, heavy fraction was collected 
by centrifugation at 2000 rpm for 10 
min. 
No water. Nanoparticles were 
collected at 2000 rpm (10 min) and 
remaining in the supernatant at 5000 
rpm (15 min) 
No water. Nanoparticles were washed 
twice with ethanol, once with water 
and collected at 5000 rpm (15 min ). 
Hydrodynamic 
diameter, nm 
180.614.4 (in water) 
439.7±10.85 nm (in ethanol), 
680.9±8.0 nm (in water), 
<300 nm (SEM) 
293.3±7.7nm in ethanol 
242.9±4.2 nm (in ethanol) 
201.9±5.9 nm (in ethanol, 
supernatant) 
244.1±6.2 nm (in alcohol), 
334.2±15.0 nm (in water). 
<250 nm (SEM) 
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Figure 3.3: SEM images of nanoparticles obtained from experiment S-2 (Table 3.4). 
Images were taken after sputter coating the dried sample with 2 nm thickness of Iridium. 
Influence of Solvent on 
Calcium Alginate 
Nanoparticle SEM Imaging 
While a drop of calcium alginate suspension (sample S-4) in ethanol was applied 
to Si surface and dried overnight, particles smaller than 250 nm are clearly visible (Figure 
3.4). There are many particles of much smaller sizes (less than 100 nm). For the sample 
prepared from aqueous solution (Figure 3.5), there is bigger agglomeration but small size 
particles are still visible. The fact that SEM images in both cases are not resolved 
completely can be related both with sample preparation conditions and with mage 
recording conditions (small soft organic particles are difficult to visualize). While the 
samples for SEM were prepared from water, the nanoparticles are probably swollen and it 
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can affect their alignment during drying causing high agglomeration. The partial 
dissolution of nanoparticles can also be considered as a reason. The samples prepared 
from ethanol can be affected by air moisture. 
Figure 3.4: SEM images of nanoparticles obtained from experiment S-4 (Table 3.4) after 
washing with ethanol and before washing with water. Images were taken after sputter 
coating the dried sample with 2 nm thickness of Iridium. 
Figure 3.5: SEM images of nanoparticles obtained from experiment S-4 (Table 3.4) after 
washing with ethanol and water. Images were taken after sputter coating the dried sample 
with 2 nm thickness of Iridium. 
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Preparation of Calcium 
Alginate Nanoparticles Using 
Nonaqueous Solution of 
CaClz 
Since it was found that CaCl2 is soluble in ethanol [115], an attempt was made to 
avoid addition of a second water-based solution (CaCb solution) during nanoparticles 
preparation by replacing it with ethanolic solution of CaCl2. Ethanol is mixable with 
isooctane and it can avoid disruption of nanoparticles. 
Emulsion of 5g 3%alginic acid in 54.2 mL isooctane+1.7 g SPAN85 was added to 
20 mL 10% CaCh in ethanol under stirring for 30 min. SPAN85 was extracted with 
isooctane tree times. Nanoparticles were washed with ethanol four times using 
centrifugation at 3000 rpm for 5 min. SEM for this sample gives wide size distribution, 
some particles around 1 micron, small particles less than 300 nm. Measured nanoparticle 
size is 343.1±4.3 nm (in ethanol, average of 3), 304.4±9.2 nm (in water, average of 3). 
There are big (around 1 micron) particles as well as smaller (less 300 nm) 
particles in the sample (Figure 3.6). The images were taken at the edge of the sample, 
where individual, non-agglomerated particles were found. 
Figure 3.6: SEM images of nanoparticles obtained from Sample 8 (Table 3.1). Images 
were taken after sputter coating the dried sample with 2 nm thickness of Iridium. 
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Influence of Viscosity of 
Alginic Acid on Calcium 
Alginate Nanoparticles 
To investigate the influence of molecular weight of the polymer on properties of 
calcium alginate nanoparticles, samples of alginic acid from different sources were used. 
They are characterized by different viscosity, the parameter related to molecular weight 
of alginic acid, and also different G/M ratio. The galacturonic acid, a main component of 
pectin, which also can be gelated by Ca2+ ions, was used for comparison. All 
nanoparticles were prepared using separate emulsification of alginic acid and CaC12, 
followed by addition of alginic acid emulsion into CaC12-containing emulsion. To extract 
SPAN85, the modified procedure was used, which consists of addition of 500 ml DI 
water, 100 ml ethanol and 50 ml of isooctane to the reaction mixture in a separation 
funnel, followed by the second extraction of the surfactant with 50 ml of isooctane, and, 
finally, two washings with ethanol using centrifugation at 5000 rpm for 10 min to 
separate then nanoparticles. From the results presented in Table 3.5, nanoparticles 
prepared from alginic acid of high viscosity have relatively lower diameter as compared 
with those obtained using low and medium viscosity samples. While one of the latter was 
used, diameter of nanoparticles varied drastically from sample to sample. In spite the fact 
that alginic acid of low viscosity can provide big fraction of nanoparticles with a diameter 
smaller than 100 nm, the nanoparticles have a wider size distribution (higher 
polydispersity) and uneven nanoparticle surface (Figure 3.7). On the basis of the obtained 
results, alginic acid of high viscosity can be recommended for preparation of 
nanoparticles with size less than 300 nm and low polydispersity. Particles in such a 
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sample have rather good round shape (Figure 3.7). Polygalacturonic acid gives very 
nanoparticles of very small size, but their shape is uneven (Figure 3.7). 
Table 3.5: Diameter for calcium alginate nanoparticles prepared from alginic acid of 
different viscosity by emulsification technique. 
Viscosity of alginic acid/ 
manufacturer 
high viscosity /FMC 
low viscosity /FMC 
medium viscosity/Sigma 
medium viscosity/FMC 
Polygalacturonic acid/Sigma 
Hydrodynamic 
diameter, nm 
223.0 ± 9.9 
291.2+10.1 
274.8 ± 6.0 
269.1+4.9 
400.9 ± 8.0 
381.4 ±16.9 
678.7 ± 15.0 
497.5 ± 20.2 
471.4 ±13.1 
257.2 ± 6.2 
204.8 ±4.1 
Half width, 
nm 
82.9 ±11.4 
98.5 ±23.7 
92.0 ± 19.2 
82.9 ±14.6 
210.3 ±67 
205.5 ± 10.9 
366.7 ±16.8 
241.4 ±18.1 
255.9 ±11.6 
76.7 ± 14.7 
80.6 ± 8.0 
Polydispersity 
0.14 ±0.09 
0.14 ±0.04 
0.14 ±0.04 
0.10 ±0.03 
0.28 ±0.01 
0.29 ± 0.04 
0.29 ± 0.05 
0.24 ± 0.02 
0.29 ± 0.01 
0.11 ±0.03 
0.16 ±0.02 
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Figure 3.7: SEM images of calcium alginate nanoparticles prepared using alginic acid of 
high viscosity (upper row) and low viscosity (middle row) and using polygalacturonic 
acid (lower row). Images were taken after sputter coating the dried sample with 2 nm 
thickness of Iridium. 
Chitosan Coating onto 
Calcium Alginate 
Nanoparticles 
It has been shown that calcium alginate particles are chemically unstable when 
chelators such as phosphate and citrate and nongelling cations such as sodium or 
magnesium ions are present [33]. To increase the stability of alginate microparticles and 
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to minimize the loss of encapsulated material, the microparticles are coated with 
polycationic polymers of poly-L-lysine [24, 34], polyvinylamine [35], and chitosan [26, 
27, 36, 37]. 
Chitosan, a polycationic polysaccharide derived from the natural polymer chitin, 
forms polyelectrolyte complexes with alginate, a polyanionic polymer [38, 39]. The 
addition of cationic chitosan, resulting in chitosan-coated alginate microparticles, further 
strengthens the alginate gel structure of microparticles [37]. As prepared, calcium alginate 
nanoparticles have a surface charge of -34.12 ± 1.23 in water. Coating of the 
nanoparticles with a layer of chitosan using the Layer-by-Layer technique reverses the 
surface charge to 8.58 ± 2.70 mV. However, the coating causes the nanoparticles to 
agglomerate, forming particles of bigger size (Figure 3.8). 
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Figure 3.8: SEM images of calcium alginate nanoparticles before (A,B) and after (C,D) 
coating with one layer of chitosan. Images were taken after sputter coating the dried 
sample with 2 nm thickness of Iridium. 
Encapsulation and Release of 
Curcumin 
The encapsulation of the curcumin was observed by CLSM images (Figure 3.9) 
and SEM microscopy (Figure 3.10). The release kinetics in comparison with the 
curcumin naked crystals is shown in Figure 3.11. The release kinetics study shows the 
enhanced dissolution profile of curcumin from chitosan alginate microspheres. The 
enhanced dissolution might be due to the use of a organic solvent (in this case 
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hexadecane) during the encapsulation process. It was clear from the CLSM images that in 
aqueous phase curcumin remains in a dissolved condition inside the chitosan-alginate 
matrix (as shown by innate fluorescence of curcumin), and in SEM images it remains as 
crystals in dried condition (absence of hexadecane). Due to the presence of chitosan and 
its nature to form aggregation (as per previous results) the formed alginate particle size 
was around 566 ± 17.5 nm, and the surface charge of the curcumin loaded alginate 
particles was measured around -10.78 ± 0.67 mV. The amount of curcumin loaded was 
O.Olmg/ mg of microspheres (1% by mass, determined by complete dissolution of 
curcumin using ethanol). 
Figure 3.9: CLSM images of Curcumin loaded chitosan-alginate particles. Fluorescence 
was due to innate nature of curcumin. 
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Figure 3.10 SEM images of Curcumin loaded chitosan-alginate particles. Images were 
taken after sputter coating the dried sample with 2 nm thickness of Iridium. 
0.25 
Figure 3.11: In vitro release kinetics of Curcumin in deionized water at pH 6.5. 
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Conclusion 
By the emulsion method Ca-alginate nanoparticles with a diameter less than 300 
nm can be prepared. According to SEM the particle size is less than 200 nm. Separate 
emulsification of alginic acid and calcium chloride followed by mixing the emulsion and 
continuous stirring (see Exp-4 above) gives relatively better results than other 
approaches. The procedure consist of separate emulsification of 10 ml of 10% CaC12 
solution in water and 5 g 3% alginic acid sodium salt in 37.5g (54.2 mL) isooctane 
containing 1.7 g SPAN 85 each by sonication at 90% power for 30 min. During 
sonication the batches were iced. Then alginic acid emulsion was added to the emulsion 
containing calcium chloride under vigorous mixing and stirred for 30 min. 
Nanoparticle size depends on emulsion preparation parameters and the following 
parameters made a positive influence on making smaller size Ca-alginate nanoparticles: 
- Large oil-to-water ratio for alginate emulsions gives smaller particle size. 
Smaller concentration of alginate solution used for emulsion preparation also seems to 
decrease particle size. 
- SPAN85 alone without TWEEN gives smaller particle size. 
- Mixing two separate emulsions of reagents gives smaller particle size 
Decrease in emulsion stability or no reduction in particle size was found for the 
experiments, in which 
- Chloroform was used in oil phase. Stability of emulsions drastically decreases. 
- AOT does not stabilize the emulsions to sufficient degree. 
- Ca-AOT as a gelling agent-surfactant increases nanoparticle size. 
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Multiple extraction of SPAN85 with isooctane followed by washing nanoparticles 
with ethanol several times can remove SPAN85 from the samples almost completely. 
The encapsulation of the curcumin in chitosan alginate particles resulted in bigger 
size particles and in vitro release kinetics study showed an enhanced dissolution in 
comparison to the naked curcumin crystals. 
CHAPTER 4 
ENCAPSULATION AND SUSTAINED 
RELEASE OF POORLY SOLUBLE 
DRUGS USING NATURAL CLAY 
NANOTUBULAR TEMPLATE 
HALLOYSITE 
Introduction 
Halloysite (Al2Si205(OH)4.2H20) is a two-layered aluminosilicate which has a 
predominantly hollow tubular structure in the submicron range and is chemically similar 
to kaolin [48, 49]. It occurs naturally and can be mined as a raw mineral, making it 
economically viable. Neighboring alumina and silica layers, and their waters of 
hydration, create a packing disorder which causes the layers to curve into tubes. 
Dehydrated halloysite consists of 15 -20 clay layers rolled into tubule walls with a layer 
spacing of 0.7 nm [51]. Halloysite obtained from the Atlas Mining Company was used in 
this work. These tubules have an external diameter of 50 ± 10 nm and a lumen of ca 15 
nm when completely rolled [49, 66]. The use of halloysite nanotubes offers significant 
advantages over other nanotubes. Because it occurs in nature, production is neither 
tedious nor hazardous. It is inexpensive in comparison with other nanotubes in use 
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(carbon nanotubes, and inorganic nanotubes made of tungsten, titanium etc). The loading 
procedure is simple. 
Halloysite is a promising biocompatible material for encasing and sustaining 
the release of bioactive molecules for pharmacology and tissue scaffolds [49, 55, 56, 63, 
66, 116, 117]. Although usage of halloysite for loading and slowly releasing some 
hydrophilic drugs has been demonstrated, its effectiveness in delivering poorly soluble 
drugs (which constitute the majority of therapeutics) was not studied. Herein this chapter 
describes the use of halloysite nanotubules for the entrapment, storage, and subsequent 
release of three drugs: nifedipine (anti-anginal), furosemide (anti-hypertension and 
diuretic) and dexamethasone (synthetic corticosteroid).The chemical formulae of these 
drugs are shown in Figure 4.1. To increase loading of these poor soluble drugs, we loaded 
them in water-alcohol solvents (0, 10, and 50 % ethanol). The effect of pH on the loading 
and release of dexamethasone was also studied. Halloysite is non toxic to cells, but its 
biodegradability is unclear; therefore, its use in medicine for sustained drug release is 
feasible for dermatological and dental applications. 
H5C LOH 
H3C 
0 V 0H 
0 
0 CI 
Figure 4.1: Chemical formulae of the drugs used: a-Dexamethasone (MW 392.5), b-
Furosemide (MW 330.8), and c-Nifedipine (MW 346.3). 
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Materials and Methods 
Processed halloysite G was purchased from Atlas Mining Company in Utah. 
Furosemide, dexamethasone and nifedipine were bought from Spectrum Chemicals and 
Laboratory Products. The solvent ethanol was obtained from Sigma. 
Surface Characterization 
The surface potential of the halloysite at different pH levels was determined using 
Zeta-potential micro-electrophoresis measurements (Zeta Plus Brookhaven Instrument). 
Drug Loading 
Loading was performed by vacuum pulling saturated solutions of the drugs in 0, 
10 and 50 % ethanol/water solvent in two steps. In the first step, pre-weighed halloysite 
(ca 10 mg) was soaked in saturated drug solution, vacuum pulled, and broken twice. The 
halloysite was extracted by centrifugation. In the second step, the removed halloysite was 
further soaked in saturated drug solution and the same procedure repeated. Finally, the 
tubules were washed using DI water and vacuum dried. All processing took 30 min 
exclusive of vacuum drying. In another set of experiments, the loading of a drug was 
performed using 10 mM PBS buffer at different pH (1.4, 7.4, and 9.4). 
In Vitro Drug Release 
Kinetics 
The drag dissolution studies were performed using diffusing chambers of 1 mL 
capacity from Permegear Incorporation. The released drug diffused through a 0.2 micron 
membrane filter to the other side of the chamber. Time-based samples were taken from 
the chamber for drug concentration determination by UV-Vis spectrophotometer 
(Agilent-8453). For monitoring Furosemide, Dexamethasone, and Nifedipine 
concentrations, an absorbance study was performed at 277 nm, 240 nm, and 235 nm at 
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22° C. The rate of release was calculated based upon assuming 90 % release during 1 
hour sonication of the loaded tubules. 
Results and Discussion 
The Zeta-potential surface charge measurements of the halloysite are shown in 
Figure 4.2. Zeta potentials for silica and alumina nanoparticles are also given and may 
represent the behavior of the outer and innermost of halloysite nanotubules respectively. 
The surface potential of the halloysite falls between the curves of silica and alumina, 
indicating the predominance of silica properties on its exterior surface as earlier indicated 
[50]. The input of alumina features may be due to incompletely rolled tubes or to the 
exposure of some inner alumina layer at the non-geometric ends of the tubes (tube 
surface defects). 
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• Alumina 
• Silica 
• Halloysite 
PH 
Figure 4.2: Zeta Potential results of halloysite, silica, and alumina. 
Below pH 8.5, the tubule's lumen has a positively charged surface and the outer 
surface has a negatively charged surface. This charge difference on surface promotes the 
loading of negatively charged molecules (such as chosen drugs dexamethasone, 
nifedipine and furosemide) specifically inside the lumen and prevents their adsorption 
onto the negative outer surface of the tubules. The chosen drugs are poorly soluble in 
water; the solubility of dexamethasone in water is 0.1 mg/mL, for nifedipine it is 0.05 
mg/niL, and for furosemide it is 0.1 mg/mL Hence, loading was performed from aqueous 
solvents containing 10 % alcohol, which provided higher solubility for the drugs. The 
release condition was maintained at pH 7.4 and continuous body sink conditions were 
maintained to simulate physiological conditions. The release profiles of the drugs from 
halloysite in comparison with those of the drug microcrystals are shown in Figure 4.3a. 
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The drug release from the halloysite tubules was much longer than that from the micro-
crystals. For nifedipine, it was 25 times longer from the tubules than from the crystals, 
and in the case of furosemide and dexamethasone it was 75 times longer. In all three 
release curves, an initial burst within 10 min followed by a 6-10 hour release can be 
observed. The initial burst may be due to release from exogenously bounded drugs on the 
surface of the tubes. 
The next experiments were performed to optimize drug loading using saturated 
solutions in 0 %, and 50 % ethanol solvents. Drug loading was higher at higher alcohol to 
water ratios. For 0 % alcohol, 3 wt % of the drugs were loaded; for 10 % alcohol, 4 wt % 
were loaded; and for 50 % alcohol, 5 wt % were loaded. The release became more linear 
for loading from higher alcohol ratio solvent. Linear release means that the rate of release 
remains constant over time, which is a desirable attribute for medicine. Figure 4.3b shows 
that release became more linear for loading from higher alcohol ratio solvent. 
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Linear four-hour release of nicotinamide adenine dinucleotide (NAD) from halloysite 
was achieved by increasing the viscosity of the loading solvent. Similar linear behavior 
was observed for cytochalasin release through nanopores by Berg et al. [118]. The release 
profile from the halloysite fits the Peppas model [119] (Mt/Ma = ktn, where Mt is the 
amount of drug released at time t, Ma is the amount of drug released at infinite time, n 
is the exponent characteristic of the release mechanism, and k is a constant). For the 
cases of loading in 10% alcohol and release in water, the value of n is around 0.5 for all 
three drugs, indicating that the release mechanism is Fickian diffusion. In the case of 
loading using 50 % ethanol and release in water (Figure 4.3b), the value of n is around 
0.75 for the drugs, indicating that the release mechanism is approaching zero-order 
kinetics (for which the value of 'n' is 1) [119]. This linear release might be due to heavier 
loading of the drug inside the halloysite tubules, giving us a nanopore controlling release. 
The absence of this mechanism in the cases of loading in 10 % alcohol and in water 
might be due to smaller amounts of the drug being spread along the lumen walls and not 
closing the tube opening. Therefore, an extended 10-20 hour drug release from 15 nm 
lumen diameter tubular halloysite was demonstrated. Using an alcohol drug solution for 
loading allowed for larger loading and linear release that was close to zero-order 
mechanisms. On assumption that no loading occurs between rolled layers, then maximum 
loading in the lumen is equal to r2/(R2-r2), which is ca 14 volume % (where R = 25 nm 
is outer radius, and r = 7.5 nm is lumen radius). The optimized experimental conditions 
yielded ca 5 wt % and 13 volume % ratios (taking the density of halloysite to be 2.53 
g/cm3).2 No drug was inserted between halloysite clay layers in the roll, as confirmed by 
preserved 7.2 A packing X-ray reflection. It was indicated that it is possible to intercalate 
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only ethylene glycol or small ions by drying hydrated halloysite (halloysite-10 A) in the 
presence of NH4-, K-, Cs-, Rb-salts [49]. For this experimental setup, thermodynamically 
stable dehydrated halloysite-7 A, which does not allow intercalation, was used [51]. 
It is difficult to judge how much of the drugs were adsorbed on the surface of the 
tubes. Before each release experiment, the loaded halloysite was washed with large 
amounts of water for 5 min to ensure removal of material from the surface. However, it is 
difficult to exclude some materials that may still have been attached to the outer surface, 
especially in the natural gap-defect on the cylinder surface at the end of the rolled clay 
sheet (it is a natural pocket on the tubule surface). The typical 5 - 10 % initial release 
burst may be related to the dissolution of this externally attached matter. To have better 
washing initially, washing was done with the same solvent which was used for loading, 
but heavy loss of the drug in washing was observed. This result might be due to the 
washing of loaded drug by the high-solubility solvent. Hence, DI water was opted for, 
which is good at removing the loosely bound particles and causes minimum loss to the 
particles loaded inside the lumen. 
In the pH range of 4-7, surface charge in the tubule lumen is positive and 
surface charge on the external surface is negative. This factor allowed for more efficient 
loading of halloysite with negatively charge molecules at lower pH as demonstrated in 
Figure 4.4a for Dexamethasone. At low pH, the loading was maximal at 5.5 wt %. At 
higher pH, the loading was less than 2-3 wt %. Thus, low pH facilitates to reach a loading 
amount close to that of the 50 % alcohol solvent. Dexamethasone release was observed in 
water at pH 7.4 (Figure 4.4 b).A similar release rate for different loadings, but the initial 
drug burst associated with quick dissolution of externally attached drug was larger for 
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lower pH. This might indicate that at low pH, some of loaded material can be associated 
with undesirable external deposition (not in the lumen). A maximum loading of 5.5 wt % 
at pH 1.4 when both lumen and outermost surface are positive is close to full loading 
capacity (ca 14 volume %). Minimal 2 wt % loading was performed at pH 9 when both 
halloysite lumen and Dexamethasone had the same negative charge, and it corresponds to 
the loading of only one third of the lumen volume. 
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Conclusion 
An extended 6-10 hours drag release from 15-nm lumen diameter tubular 
halloysite has been demonstrated for dexamethasone, furosemide, and nifedipine. By 
optimizing solvents with pH and alcohol content, the highest loading of 12 volume %, 
which is close to the theoretical capacity of these nanotubules, was obtained. Maximal 
loading resulted in more linear release (close to zero-order release mechanisms for 
dexamethasone and furosemide). 
CHAPTER 5 
TUNABLE CONTROLLED RELEASE OF 
DEXAMETHASONE USING 
LAYER-BY-LAYER 
FORMULATED 
HALLOYSITE 
Introduction 
The usefulness of any drug is based not only on its effect on the disease but also 
on how specifically, how readily, how controllable and how prolonged its effect on the 
disease without having any side effects. Thus the techniques involved in the drug 
encapsulation and its controlled release forms one of the important processes of drug 
formulation. In recent years nanotechnology, through its arms of nanomedicine and 
biomedical nanotechnology, is revolutionizing the field of pharmaceuticals. Its 
applications makes use of the properties of nanoparticles as drugs or constituents of 
drugs as a novel design or strategies to controlled release, drug targeting, and making 
availability of low bioavailability drugs [120-122]. These more complex submicron or 
nanosized drug delivery systems are either self-assembling or involve covalent 
conjugation of multicomponent systems, e.g., drug, protein and polymer. The 
bioresponsive or biomimetic materials used to create such drug delivery systems typically 
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include synthetic or semi-synthetic polymers, and natural materials such as lipids, 
polymers and proteins. One such submicron or nanosized drug delivery system discussed 
in this chapter is the ceramic-based naturally available clay nanomaterial called 
halloysite. In spite of its huge advantage of having a high availability to cost ratio over 
other conventional nanotubes like carbon nanotubes, metallic nanotubes etc, halloysite 
has received only meager attention by the scientific community in the last 10-15 years. 
But even with a very little attention, in perspective halloysite has been shown as a 
promising material for various fields of nanotechnology application [50, 52, 64]. The 
inner positively charged lumen surface of halloysite nanotubes was used to fill with a 
large range of organic and biologically active agents including lubricants, herbicides, pest 
repellents, pharmaceuticals, cosmetics, food and personal products, as well as other 
agents that could benefit from a controlled release [49, 51, 55, 56, 123]. The combined 
use of charge difference in outer and inner surfaces of halloysite was recently exploited 
for loading benzotriazole (corrosion inhibitor) and encapsulation of the loaded halloysite 
by Schukin et al. [124]. In this chapter a detailed study of the halloysite as a template for 
LbL assembly and its utilization for the controlled delivery of the chosen drug 
dexamethasone is presented. The various advantages of LbL assembly like its thickness 
tunability in nanometer range control over permeability of the nanoshells, modification of 
surface property and simple process has overruled the selection of other encapsulation 
techniques [76-82]. Control over the drug release was studied by observing the effect of 
number of assembled layers and the effect of molecular weight of the assembled 
polymers on the release rate. 
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Materials and Methods 
Processed halloysite was obtained from Atlas Mining Corporation and used 
without any further treatment. Polyelectrolytes such as poly-allylamine (PAH, MW 
70000 and MW 15000), poly-styrene sulfonate (PSS, MW 70000 and MW 32000), poly-
ethyleneimine (PEI, MW 1100), and poly-acrylic acid (PAA, MW 5200), were purchased 
from Sigma Aldrich, USA. Also natural polymers such as chitosan (MW 1 million), 
gelatin from bovine skin, type-B (Gelatin-B, MW 70000), and silica nanoparticles (7nm 
and 22nm diameter) were purchased from Sigma Aldrich, USA, and used as such. The 
drug dexamethasone was purchased from Spectrum Chemicals and Laboratory Products, 
CA, USA. 
Layer-by-Layer Assembly on 
Halloysite 
LbL assembly on halloysite was done by following a traditional procedure as 
described elsewhere [82, 84, 103]. In our case, negatively charged halloysite nanotubes 
were used as template with PAH, (MW 70000 and MW 15000), PEI (MW 2000), and 
chitosan (MW 1 million) as polycations and PSS (MW 70000 and MW 32000), PAA 
(MW 5100), Gelatin-B (MW 70000), and silica nanoparticles (7nm and 22nm diameter) 
as polyanions. Typically polycations (0.75 ml of 3 mg/ml in deionised (DI) water) and 
polyanions (0.75 ml of 3mg/ml in DI water) were alternatively added in to 0.75 ml of 
halloysite suspension in DI water (~10 mg). Then, two intermediate washings were done 
with DI water using centrifugation speed at 5000 rpm for 5 min at room temperature 
(Eppendorf 5804R Centrifuge) to remove the unadsorbed polymers before the next layer 
was assembled. 
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Characterization of 
Assembled Layers 
The assembly of layers on halloysite template was confirmed by monitoring 
Quartz Crystal Microbalance resonant frequency changes (QCM, USI-Systems, Japan), 
and observing the surface charge alternation after deposition of each layer using a Zeta 
Potential analyzer (Brookhaven Instruments Corporation). Assembly of silica 
nanoparticles was visually confirmed by taking Transmission Electron Microscope 
(TEM) images (ZEISS-LIBRA 120 KV). 
Dexamethasone Loading 
The loading of halloysite with drug was achieved by following the procedure as 
described in earlier work [123,49,124] with slight modifications. In the first step the pre-
weighed halloysite (around 10 mg) is mixed with 5 mg of dexamethasone and made into 
thick paste by adding 50 uL of DI water and sonicated for 30 min for proper mixing, and 
then vacuum pulling and breaking done several times until the fizzing stopped for 
loading. Then finally the tubules were washed with DI water twice (centrifugation speed 
at 5000 rpm for 1 min at room temperature) and vacuum dried. The loading of the drug 
was confirmed by porosity test using mercury porosimeter (Micromeretics). Around 
lOOmg of dry halloysite powder (loaded or unloaded) was taken, and mercury was forced 
through the pore volume of the sample by slowly increasing the pressure up to 30000 psia 
using micromeretics porosimeter equipment. At each stage of pressure the amount of 
mercury intruded into pores was used to evaluate the pore volume. 
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Encapsulation of Drug-
Loaded Halloysite 
Encapsulation of the drug loaded halloysite was achieved by LbL assembly. The 
same above mentioned LbL assembly procedure was followed except for the washing 
speed and time modified to 8000 rpm and 1 min to avoid the loss of loaded drug. 
In Vitro Dexamethasone 
Release Kinetics 
The in vitro drug dissolution studies were performed using 2ml centrifuge tube. 
Known amount of dry encapsulated drug in halloysite nanotubes (~10mg) was taken and 
suspended in 1.5ml of DI water with continuous stirring at 500 rpm. From this 
suspension, time-based samples (750 uL) are collected from the supernatant of this 
mixture after centrifuging it at 8000 rpm for 1 min. For each sample taken, an equivalent 
amount of fresh DI water is added and the halloysite is resuspended. The concentration of 
the drug in the collected samples was determined by UV-Vis spectrophotometer (Agilent-
8453). For monitoring dexamethasone the absorbance was studied at 240 nm. The total 
amount of drug loaded was calculated based upon complete release from the encapsulated 
nanotubes (till no absorbance peak was observed in spite of sonicating the final sample 
for an hour). 
Results and Discussion 
First, halloysite was established as a nanotubular template for LbL assembly by 
adsorbing layers of PAH(MW 70000)/PSS(MW 70000), PEI(MW 2000)/PAA(MW 
5100), and PEI(MW 2000)/Si nanoparticles, then later on we extended LbL assembly for 
the encapsulation of dexamethasone-loaded halloysite for controlled release. Figure 5.1 
explains the illustration of the entire assembly process. 
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Polyelecfrolyte/Polymer Nanoparticle deposition 
deposition 
Figure 5.1: Schematic illustration of layer-by-layer assembly of polymer/nanoparticle 
coating on halloysite and halloysite loaded with drug. 
The zeta potential surface charge alternation for each layer adsorption of 
PAH(MW 70000)/PSS(MW 70000) and PEI(MW 2000)/PAA(MW 5100) was shown in 
Figure 5.2. For Silica nanoparticle adsorption (7nm and 22nm diameter) 1.5 bilayer of 
PEI(MW 2000)/PAA(MW 5100) was used as a precursor layer and 2.5 bilayer of 
PEI(MW 2000)/PAA(MW 5100) was used as an intermediate bed layer for second layer 
adsorption of silica nanoparticles. The zeta potential surface charge alternation for each 
layer polymer and nanoparticle adsorption was shown in Figure 5.3. Complete alternation 
of charge was observed until the first layer of nanoparticle coating after that only 
reduction of positive charge was observed. This result might be due to the heavy 
adsorption of low molecular weight PEI (2000) over silica nanoparticle layer, followed 
by less adsorption of higher molecular weight PAA (5100). The growing of the thickness 
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of polymer/nanoparticle layer around halloysite was monitored using QCM and shown in 
Figure 5.4. The bilayer thickness of PEI (MW 2000)/PAA (MW 5100) is around 1-3 nm 
and the average thickness of 7 nm diameter silica nanoparticle layer is around 6-8 nm and 
of 22 nm diameter silica nanoparticle is around 14-16 nm. The adsorption of silica 
nanoparticles was also observed by TEM, the images are shown in Figure 5.5 for silica 
nanoparticles having 7 nm diameter and in Figure 5.6 for silica nanoparticles having 22 
nm diameter. A uniform coating of silica nanoparticle is observed for both 1st layer and 
2nd layer of nanoparticle coatings in the case of lesser diameter particles (7 nm), for 
higher diameter nanoparticles (22 nm) uniform coating is observed only for 2nd layer of 
coating. 
-80 J 
Layers 
Figure 5.2: Zeta potential readings of four bilayer coating of PAH(MW 70000)/PSS(MW 
70000) and PEI(MW 2000)/PAA(MW 5100) on halloysite at pH 6.5. 
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Figure 5.3: Zeta potential readings of layer-by-layer coated polymers (with PEI(MW 
2000)/PAA(MW 5100)) along with silica nanoparticles (7nm and 22nm in diameter) on 
halloysite at pH 6.5. 
To confirm qualitatively the loading of dexamethasone by the modified procedure 
mentioned above, the porosity of the dexamethasone-loaded halloysite nanotubes was 
compared with the porosity of the unloaded nanotubes using mercury porosimeter. Figure 
5.7 shows the reduction in the pore volume for the dexamethasone loaded nanotubes. 
Quantitatively the porosity of the unloaded halloysite reduced from 67.7% to 50.5% on 
loading of dexamethasone. 
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Figure 5.4: Film thickness monitoring by Quartz crystal microbalance studies for polymer 
(PEI(MW 2000)/PAA(MW 5100)) and nanoparticle (silica nanoparticles 7nm and 22nm 
in diameter) assembly. 
1s t layer of 7nm dia Si nanoparticle 2nd layer of 7nm dia Si nanoparticle 
Figure 5.5: Transmission electron microscopy image of Si nanoparticle with diameter of 
7nm assembly on halloysite. 
83 
100 nm 
2nd layer of 22nm Si nanoparticle 
Figure 5.6: Transmission electron microscopy image of Si nanoparticle with diameter of 
22nm assembly on halloysite. 
Encapsulation of the dexamethasone-loaded halloysite was done using layers of 
PEI(MW 2000)/PAA(MW 5100) and later on extended to various polymers of different 
molecular weight. The effect of the number of adsorbed layers on the release rate of 
dexamethasone was studied using several bilayers of PEI(MW 2000)/PAA(MW 5100). 
Figure 5.8 shows zeta potential surface charge alternation for each layer adsorption of 
PEI(MW 2000)/PAA(MW 5100) on dexamethasone-loaded halloysite. The release 
profiles of dexamethasone from the LbL (1, 3, 6, and 9 bilayer of PEI(MW 
2000)/PAA(MW 5100)) formulated composite was compared with uncoated (0 bilayer) 
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halloysite loaded with drug in Figure 5.9. A very marginal and decent retardation in the 
release rate was observed for 1 & 3 bilayer coated samples when compared with uncoated 
halloysite loaded with drug. Whereas in the case of 6 & 9 bilayer coated samples the 
release rates of dexamethasone where found to be increased, it was due to heavy loss of 
dexamethasone during the LbL assembly which resulted in a lesser quantity of final 
loaded drug, hence the faster release. Similar results were observed earlier in Chapter 2 
[123]. Hence, an optimum number of bilayers were required for retardation, in our case 
the optimum being 3 bilayers. The decent retardation achieved for 3 bilayers might be 
due to low molecular eight of the compounds used for encapsulation (MW 2000 and MW 
5100). 
To confirm the significance of molecular weight of the assembled polymers the 
molecular weight effect of the adsorbed polymers on the drug release rate was studied. 
Three variations of the molecular weight range has been studied: low molecular weight 
polymers PEI(MW 2000)/PAA(MW 5100), medium molecular weight polymers 
PAH(MW 15000)/PSS(MW 32000), and high molecular weight polymers PAH(MW 
70000)/PSS(MW 70000). The assembly of the above polymers over the dexamethasone 
loaded drug was studied by zeta potential measurements and shown in Figure 5.10. The 
release profiles of dexamethasone from three bilayer coated samples using three different 
molecular weight combinations of the coated polymers was compared with the release 
from the uncoated halloysite in Figure 5.11. From the release rate curves it was 
established that as the molecular weight of the coated polymer increases the retardation 
of the drug increases further for the same number of layers. This increase in retardation 
can be attributed to the mechanical and chemical stability of the formed layers to harsh 
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conditions which has molecular weight greater than 10000 [125]. With the shown control 
over the release rate of dexamethasone by LbL assembly; this clay-drug composite 
provides a novel formulation for controlled release of drugs. 
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Figure 5.7: Mercury porosimeter results of dexamethasone loaded halloysite in 
comparison with unloaded halloysite. 
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Figure 5.8: Zeta potential readings of LbL coating of (PEI(MW 2000)/PAA(MW 5100)) 
halloysite loaded with dexamethasone drug. 
Time in hr 
Figure 5.9: Effect of number of bilayers on the release profile of dexamethasone drug in 
deionised water at pH 6.5 from LbL (PEI/PAA) coated halloysite loaded with 
dexamethasone. 
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Figure 5.10: Zeta potential readings of layer-by-layer coated halloysite loaded with 
Dexamethasone drug. 
0 1 2 3 4 5 6 
Time in hr 
Figure 5.11: Molecular weight effect of the coated polymers on the release profile of 
dexamethasone drug in deionised water at pH 6.5 from LbL coated halloysite loaded with 
dexamethasone. 
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Though halloysite is biocompatible, some of the polymers used for encapsulation 
are not FDA approved; hence it is necessary to shift to natural polymers for the 
encapsulation to use this novel formulation for real life applications. To ensure that 
whatever has been observed with polymers is also possible with natural polymers, a very 
high molecular weight natural polymers chitosan (MW 1 Million) and Gelatin B (MW 
70000) are chosen for LbL encapsulation by following the earlier mentioned procedure. 
Figure 5.12 shows the zeta potential surface charge alternation for each layer 
adsorption of Chitosan (MW 1 Million) and Gelatin B (MW 70000) on dexamethasone 
loaded halloysite and the release rate in comparison with all other earlier methods was 
shown in Figure 5.13. This release rate comparably slower than the release rate of high 
molecular weight polymers used earlier might exist because of higher molecular weight 
of chitosan Hence in encapsulation, retardation and biocompatibility natural polymers are 
having advantage over conventional polymers used for LbL assembly in making novel 
drug-clay composite formulations. 
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Figure 5.12: Zeta potential readings of layer-by-layer coating of very high molecular 
weight natural polymers (Chitosan and Gelatin B) on halloysite loaded with 
dexamethasone drug. 
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Figure 5.13: Molecular weight effect of the coated polymers on the release profile of 
dexamethasone drug from LbL coated halloysite loaded with dexamethasone. 
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Conclusion 
Halloysite clay was used as a nanotemplate for Layer-by-Layer assembly of 
polymers and silica nanoparticles. The LbL assembly of polymers was confirmed by Zeta 
potential & Quartz crystal microbalance. (QCM) studies and the assembly of silica 
nanoparticles were confirmed by TEM images. Lower diameter (7 nm) silica 
nanoparticles gave better uniform assembly rather than higher diameter (22 nm) silica 
nanoparticles. The LbL assembly was later extended to dexamethasone drug-loaded 
halloysite for its controlled release. The loading of drug was confirmed by reduction in 
porosity from 67.7% for empty tubes to 50.5% for loaded tubes using mercury 
porosimeter equipment. The effect of number of assembled layers and the effect of 
molecular weight of the assembled polymers on the release profile of the drug revealed 
that an optimum number of layers and high molecular weight of the assembled polymers 
gave a very slow sustained release. Encapsulation of the drags inside the lumen of the 
halloysite coupled with LbL assembly of natural polymers provides a novel formulation 
for controlled release of drugs. Our future work is to further study the assembly of 
specific nanoparticles and polymers on the clay-drug composites for targeted and as well 
as switchable drug release, for example assembly of magnetic particles can help us in 
switchable release and assembly of antibodies can help us in drug targeting. 
CHAPTER 6 
HALLOYSITE - IN VITRO CYTOTOXICITY TESTING 
Introduction 
As shown in previous chapters, LbL modified halloysite-based novel drug 
delivery systems are one of the most economically promising systems. Biocompatibility 
is one of the main prerequisites for its safe use as a drug delivery system. Although the 
biocompatible nature of halloysite can be sensed indirectly by the studies of Kommireddy 
et al. [117], when he used it as a substrate for cell attachment and proliferation and by 
Kelly et al. [56], who used halloysite as a drug delivery system and performed in vivo 
studies on dogs for the treatment of periodontitis. A comprehensive study of 
biocompatibility of halloysite has not been done. A general guideline on the testing of 
biocompatibility of materials for biomedical applications is specified in the International 
Standard Organization (ISO) 10993. In vitro cytotoxicity testing is one of the important 
biological test methods for checking the biocompatibility of a material as per ISO 
standards. Due to the presence of silica on the outer surface, the halloysite has a 
negatively charged surface. This negative charge can influence the surface contact of the 
cells electro statically as the surface charge on the cells is also negative. To have proper 
understanding about the surface interaction of the halloysite with the cells, both 
negatively charged halloysite (raw halloysite) and as well as positively charged 
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halloysite, obtained by coating the halloysite with positively charged biocompatible 
polymers like poly-L-lysine and protamine sulphate has been used for cytotoxicity study. 
Experiments 
Materials 
Processed halloysite was obtained from Atlas Mining Corporation, Utah and used 
without any further treatment. Polyelectrolyte's such as poly-Ethyleneimine (PEI, MW 
1100), and poly-Acrylic acid (PAA, MW 5200), were purchased from Sigma Aldrich, 
USA. Also natural polymers such as protamine sulphate, poly-L-lysine and sodium 
chloride salt were purchased from Sigma Aldrich, USA, and used as such. 
Layer-by-Layer Assembly on 
Halloysite 
LbL assembly on halloysite was done by following a traditional procedure as 
described elsewhere [82, 84, 103]. In our case negatively charged halloysite nanotubes 
were used as a template with PEI (MW 2000), protamine sulphate and poly-L-lysine as 
polycations and PAA (MW 5100) as polyanions. Typically polycations (0.75 ml of 2 
mg/ml in deionised (DI) water) and polyanions (0.75 ml of 2 mg/ml in DI water) were 
alternatively added in to 0.75 ml of halloysite suspension in DI water (-10 mg). Then, 
two intermediate washing was done with DI water using centrifugation speed at 5000 
rpm for 5 min at room temperature (Eppendorf 5804R Centrifuge) to remove the 
unadsorbed polymers before the next layer was assembled. 
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Characterization of 
Assembled Layers 
The assembly of layers on halloysite template was confirmed by observing the 
surface charge alternation after deposition of each layer using a Zeta Potential analyzer 
(Brookhaven Instruments Corporation). 
Cell Culture 
Two types of cells were used for cytotoxicity testing, one is 3T3 fibroblast cells 
and the other is human breast cancer MCF-7 cells. Each type of cells were grown 
separately at 37 deg C in a humidified atmosphere (95% air and 5% CO2), DMEM ( 
Dulbecco's Modified Eagle medium) supplemented with phenol red, 3% L-glutamine, 
penicillin (100 U/ml), gentamycin (100 ug/ml) and 10% foetal calf serum 
Cytotoxicity Assay 
Briefly, each type of cells was separately seeded approx.lOOOO/well cells into the 
96-well plate (flat bottom). Halloysite (both coated and uncoated) was added separately 
in three different rows around 100 (ig/ml of the medium. For positive control some rows 
were left untreated and for negative control some rows are treated with NaCl (which kills 
cells). After certain time of incubation, the plate was washed and reagent (CellTiter 96 
from promega) was added. The resulting change of color was read on a Plate Reader at 
490nm. The percentage of live cells was calculated based upon initial number of cells 
seeded. 
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Results and Discussion 
The surface modification of halloysite by LbL assembly was observed by the zeta 
potential surface charge measurements. Figure 6.1 shows the alternation of surface 
charge after each coating of polymer layers. 
Poly-L-lysine Coating 
Protamine Sulfate Coating 
Layer Number 
Figure 6.1: LbL coating of halloysite with natural polymers (poly-L-lysine and protamine 
sulphate) after coating two bilayers of PEI(MW 2000)/PAA(MW 5100) as precursors at 
pH 6.5. 
The cytotoxicity of the charged halloysite was tested after 24 hours and 48 hours 
of incubation time for both types of cells, 3T3 and MCF-7 cells. The percentage of live 
cells as determined by celltiter-96 reagent was measured for various concentration of 
testing agents (raw halloysite, poly-L-lysine coated halloysite, protamine sulphate coated 
halloysite, sodium chloride (negative control)). The results are shown in Figure 6.2 and 
Figure 6.3. 
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Figure 6.2: Viability of 3T3 cells after 24 hr (A) and after 48 hr (B) as determined by 
celltiter-96 reagent. The legend stands for 1. Raw halloysite, 2. poly-L-lysine coated 
halloysite, 3. Protamine sulphate coated halloysite, 4. Sodium chloride (negative control). 
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Figure 6.3: Viability of MCF-7 cells after 24 hr (A) and after 48 hr (B) as determined by 
celltiter-96 reagent. The legend stands for 1. Raw halloysite, 2. poly-L-lysine coated 
halloysite, 3. Protamine sulphate coated halloysite, 4. Sodium chloride (negative control). 
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From all the above plotted results it is shown that bare halloysite as well as 
natural polymer coated halloysite are non-toxic to the cells. Similar experiments 
conducted for drug (dexamethasone and furosemide) loaded halloysite also yielded 
similar results. 
Conclusion 
To conclude, the summary of the cytotoxicity test results clearly indicates that 
halloysite is a truly biocompatible material and can be used as a component in drug 
delivery systems. 
CHAPTER 7 
TEMPLATE SYNTHESIS OF SILVER/SILVER 
OXIDE NANOPARTICLES USING 
HALLOYSITE AS NANOREACTOR 
Introduction 
Metallic nanoparticles, due to their size-dependent properties and their metal-
support interaction, have provided many significant features like novel quantum confined 
effects [126, 127]. In recent years the techniques used for synthesizing these 
nanoparticles on organic and inorganic templates have increased rapidly and helped us in 
understanding the science and the controlled engineering of these nanoparticles [128]. 
This chapter explains in detail about the use of halloysite as an inorganic template for 
synthesizing silver nanoparticles. Chapter 4, Chapter 5, Chapter 6 and some recent 
scientific studies on halloysite have showed it as a promising material for encasing and 
sustaining the release of bioactive molecules for pharmacology and tissue scaffolds [49, 
63, 123]. Also silver nanoparticles as such are known to have some antimicrobial 
properties [129]. The very first use of halloysite as a nanoreactor was done by Shchukin 
et al. for synthesizing calcium carbonate [65]. The template synthesis of Silver 
nanoparticles on halloysite is very important not only from academic viewpoint but also 
from industrial viewpoint as the synthesizing method is simple, also halloysite is 
available in nature as huge deposits, so negligible cost, and the halloysite-silver 
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composite complex can be applied as thin coating to any surface. Herein, the synthesis of 
silver nanoparticles by loading silver acetate inside halloysite nanotubes and further 
reducing it by proven reducing agents like light [130], heat [131] and hydrogen gas [128] 
was reported. This in situ synthesis offers a novel way of fabricating surface modified 
clay materials, nano-rod metals, and core-shell type ceramic nanocomposites. 
Experiments 
Materials 
Halloysite Clay was purchased from Atlas Mining Corporation, Utah. Silver 
acetate and Lysozyme (from Chicken egg white) were bought from Sigma-Aldrich, USA. 
Silver/Silver Oxide Synthesis 
Three different methods have been used for template synthesis of silver 
nanoparticles. Scanning electron microscope viewing (after 2nm thickness coating with 
Iridium by sputter coater) and porosity test using mercury porosimeter was used to 
characterize the size and location of the silver nanoparticles. 
Method 1 
About 5mg of halloysite is mixed with 10 mg of silver acetate in 1ml suspension 
of DI water and sonicated for 15 min. Then loading of the silver acetate is achieved by 
pulling and breaking vacuum (100 mm of Hg) for three times. The resultant mixture is 
kept on stirring at 500rpm and heated on a hot plate at 100 deg C. The mixing is 
continuously kept on untill all the solution is completely dry (nearly 4 hrs). The resultant 
material is washed with DI water for five times using centrifuge @ 4500rpm for 5 min. 
Then the washed halloysite is heated to 300 deg C for an hour to decompose the silver 
acetate to silver. 
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Method 2 
The same steps as described in method 1 were followed except for the final step. 
After washing with DI water the washed halloysite is kept under hydrogen gas purge for 
3 hrs to reduce silver acetate to silver. 
Method 3 
About 5mg of halloysite is mixed with 5mg of silver acetate and 5mg of 
lysozyme in 1ml suspension of DI water and sonicated for 15 min. Then loading of the 
silver acetate is achieved by pulling and breaking vacuum (100 mm of Hg) for three 
times. The resultant material is washed with DI water for five times using centrifuge @ 
4500rpm for 5 min. Then the washed halloysite is exposed to normal visible light for 
nearly 8hrs to decompose the silver acetate to silver catalyzed by the enzyme lysozyme. 
Porosity Test 
For mercury porosimeter experiments around lOOmg of dry halloysite powder 
(loaded or unloaded) was taken and mercury was forced through the pore volume of the 
sample by slowly increasing the pressure up to 30000 psia using micromeretics 
porosimeter equipment. At each stage of pressure the amount of mercury intruded into 
pores was used to evaluate the pore volume. 
Results and Discussion 
The scanning electron microscope (SEM) images of unloaded halloysite are 
shown in Figure 7.1, the cylindrical nature of the halloysite and the empty lumen is 
clearly evident. Synthesis by method 1 (reduction by heat) yielded silver nanoparticles ~ 
5-25 nm in diameter and predominantly on the outer surface of the halloysite (Figure 
7.2). This might be due to high heating at 300 deg C which forced the loaded silver 
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acetate inside the lumen of halloysite to come out and deposit on the surface. There is a 
clear separation among the nanoparticles present on the surface, no aggregation observed. 
Similar observation was also made by Fu et al. when they deposited Palladium 
nanoparticles [132]. 
Figure 7.1: SEM images of unloaded empty halloysite. Images were taken after sputter 
coating the dried sample with 2 nm thickness of Iridium. 
Synthesis by method 2 (reduction by hydrogen gas) yielded silver nanoparticles 
around 5-10 nm and predominantly as a clumps on the outer surface of the halloysite 
(Figure 7.3). No coating or the presence of silver at the opening ends is observed. 
102 
Figure 7.2: SEM images of silver nanoparticles prepared by reducing silver acetate by 
heat. Images were taken after sputter coating the dried sample with 2 nm thickness of 
Iridium. 
Figure 7.3: SEM images of silver nanoparticles prepared by reducing silver acetate by 
hydrogen gas. Images were taken after sputter coating the dried sample with 2 nm 
thickness of Iridium. 
Synthesis by method 3 (reduction by light) yielded plugged halloysite nanotubes 
(Figure 7.4). No presence of silver nanoparticles on the surface of the halloysite 
observed. On comparing Figure 7.1 and Figure 7.4 the plugging is visually confirmed, 
but In order to confirm qualitatively, the porosity of the silver loaded halloysite 
nanotubes was compared with the porosity of the unloaded nanotubes using mercury 
porosimeter. Figure 7.5 shows the reduction in the pore volume for the silver loaded 
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nanotubes. Quantitatively the porosity of the unloaded halloysite reduced from 67% to 
47% on synthesis of silver by this method. 
Figure 7.4: SEM images of silver nanoparticles prepared by reducing silver acetate by 
normal light in the presence of lysozyme. Images were taken after sputter coating the 
dried sample with 2 nm thickness of Iridium. 
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Figure 7.5: Porosimeter results of halloysite loaded with silver prepared by reducing 
silver acetate by normal light in the presence of lysozyme. 
Conclusion 
The reduction of silver acetate, by proven reducing agents like light, heat and 
hydrogen gas, have consistently yielded silver nanoparticles of the range of 5-50nm in the 
macro environment, in a nanoconfinement using the halloysite nanotubules the results are 
completely different. Each method gave different sizes of silver nanoparticles and at 
different locations on halloysite tubules. Only the lysozyme-catalyzed reduction of silver 
acetate in the presence of normal visible light showed the presence of silver material 
inside the lumen; the other methods showed silver particle presence on the surface of 
halloysite tubes. Since things in the nanoworld are happening complete differently, our 
presumption of the nanoparticle formed to be silver needs to be confirmed by X-ray 
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diffraction studies, as there is a probability of the particles being silver oxide also. Hence 
our forward plan is to confirm those particles are silver and later on to show some 
application based on the location of silver nanoparticles. For example silver inside the 
lumen of halloysite can be used to study the kinetics of the antimicrobial activity of silver 
and silver nanoparticles on the outside surface of the halloysite can be used in the field 
of photonics, electronics etc. 
CHAPTER 8 
CONCLUSIONS AND FUTURE WORK 
Conclusions 
In this dissertation, two geometrically different shape templates are 
nanoengineered for controlled delivery of bioactive compounds. The first template used 
was a spherical alginate particle made from alginic acid, a biopolymer (polysaccharide) 
derived from brown seaweed, and the second was clay nanotubular template, available in 
nature deposits known as halloysite. 
This dissertation introduces the procedure and optimizes the process of alginate 
nanoparticle synthesis by emulsification technique. Alginate nanoparticles of 
approximately 300 nm in diameter can be prepared. Curcumin, a potential anti-
inflammatory and anti-cancer drug, was used to encapsulate inside the alginate 
nanoparticle in the presence of chitosan to enhance its release. 
Halloysite drug loading was optimized by varying pH and alcohol / water ratio in 
the solvent with a maximum drug loading of 12 volume %. The LbL assembly was used 
to nanoengineer the extended release of dexamethasone. The study of the effect of the 
number of assembled layers and the effect of molecular weight of the assembled 
polymers on the release profile of the drug revealed that a high molecular weight of the 
assembled polymers and an optimum number of layers gave a very slow sustained 
release. Encapsulation of the drugs, positive results of the cytotoxicity studies of the 
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halloysite, and other biomedical applications of halloysite shown by using halloysite as a 
nanoreactor for synthesizing silver nanoparticles shows that halloysite as a prospective 
biomaterial for novel formulation of controlled release of drugs. 
Future Work 
Several things can be done in the future to further build upon the obtained results. 
Further studies need to be done to advance this development such as: 
• Use of other types of drugs and proteins for encapsulation and sustained 
release using alginate nanoparticle matrix; 
• Application of LbL assembly using various polymers on the drug-loaded 
alginate nanoparticles as an additional step of control for drug diffusion; 
• Elaboration of the drug-loading study of halloysite for application in 
wound healing and cosmetics and extension of loading and release to other class of 
compounds like protein, corrosion inhibitors, etc. 
• Analysis of the reaction at the tube openings between releasing 
polycations and polyanions in the bulk solution for the formation of stoppers at the tube 
ends, which helps in achieving tunable controlled release of active ingredients. For 
example, magnetic stoppers can help us in making magnetic actuated release. 
• Loading tubules with nanoparticles (gold, silica) with diameter 
corresponding to the lumen diameter. Location of these nanoparticles in the tubes with 
the help of TEM. Using this approach to reach slow and controllable drug release. 
Comparison results with release for untreated tubules. 
• Forming decorative mixture of nanotubules (Carbon nanotube & 
Halloysite) for novel applications. 
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• Modeling and simulation studies for understanding the drug release 
kinetics from halloysite. 
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